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ABSTRACT

Nosocomial and community infections and biofilm formation from bacteria has
increased significantly through adaptation combined with overuse of broad spectrum
antibiotics. Because the world population continues to escalate, hospitals and long-term
managed care will also escalate, thereby increasing transmission of infections, lowering
patients’ quality of health. Another disease on the rise throughout the world is skin
cancer. A treatment modality that would cause less deleterious effects on the patient
would be ideal. These two seemingly different issues could be solved with one product.
First an inexpensive, safe, and non-selective antimicrobial surface coating would enhance
the hospital arena and a coating that would treat skin cancer like wearing a band-aid
would be patient friendly. We proposed two novel sub-coatings containing polymorphic
Titanium dioxide, Br200 and BrNMP. Titanium dioxide is versatile, non-selective, and
degrades compounds through photocatalytic oxidation.
The antibacterial sub-coating made of Poly(diallyldimethylammonium chloride)
solution (PDDA) and Poly(4-styrenesulfonic acid) solution (PSS) in a 1:1 ratio of 0.1M
PDDA/PSS as a 25 layer-by-layer coating on glass cover slips is known as the P subcoating. It contains Nitrogen and Sulfur molecules that were associated via low
temperature liquid deposition with Br200 or BrNMP Titania. XRD and XPS evaluations
of these P sub-coatings containing the polymorphic Br200 and BrNMP confirmed a
match with the original properties of the loose nanoparticles. P sub-coating with these
Titania under long range ultraviolet light and visible light were evaluated for Methyl
Orange oxidative-degradation to quantify photocatalytic activity. UVA irradiation of
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Br200 and BrNMP on the P sub-coating degraded Methyl Orange approximately two
times faster than the same Titania on the control B sub-coating. The B sub-coating
consisted of five mol of 3-glycidoxypropyl-trimethoxysilane mixed with 3 mol of
Tetramethyl orthosilicate, prehydrolyzed with Ethanol and brought to pH 3 with Nitric
acid.
Light intensity, wavelength, surface material characteristics, and bacterial load
affect efficiency of photo-oxidation. The super-hydrophilic nature of the polyelectrolyteTitania coating may attract and enhance photo-oxidative activity due to bacterial
adherence via hydrophilic fimbriae that attach to biotic and abiotic surfaces. Br200
demonstrated a stable working pH range including pH 3 to 4. The broad absorption edge
of the polymorphic Brookite Titania Br200 and BrNMP enhanced by the N and S
molecule surface interactions, and a narrowing of the band-gap, of the P sub-coating
exhibited superior photocatalytic oxidative degradation on bacteria compared to the
commercial P25 and vlp7000 Titania, or binder sub-coating with Titania. The
polymorphic nature of Br200 and BrNMP may delay the electron/hole recombination
centers due to electron transfer to different phases of crystallites.
The LB sub-coating provided the polymorphic Titania with superior
photocatalytic activity as compared to the P25 commercial product in vitro on HT-29
human colon cancer cells and HTB-67 Human Melanoma cells. The novel P sub-coating
with polymorphic Brookite Titania can provide a low cost, effective method for
decreased transmission of bacterial infections and biofilm formation in the healthcare
arena and community setting. The novel format of using FDA approved liquid band-aid
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coated with Br200 non-selective Titania coating can provide lower pain and scarring in a
topical format cancer treatment.
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CHAPTER ONE
INTRODUCTION

1.1 Uses and Characteristics of Titania as a Photocatalyst
Titanium dioxide is a versatile compound that is used in many applications,
industries, materials, and products throughout the world. It is used in pigments due to its
extremely high refractive index of n = 2.7 [1]. The Huntsman Pigments Company,
(Billingham, England) produces Rutile phase pigments for architectural paints for use in
highly opaque surface coatings, powder coatings, plastics, inks, and paper applications.
Anatase phase pigment is used for delustring synthetic fibers such as polyester and
optical brighteners in ceramics. Photovoltaic solid-state hetero-junctions comprising a
dense TiO2 film electrode as an electron conductor is another product [2]. In a medical
application, a high compressive strength (>2 MPa) titanium oxide scaffold may be used
in bone [3]. Hair dye, sun screens, and cosmetics are popular Titania containing products
[4]. Chemical vapor deposition using Anatase phase for self-cleaning, super hydrophilic,
antimicrobial glass [5].

Photomineralization with air and water purification,

photoelectrodes as a hydrolysis catalyst, and photosterilization in sterilizing, deodorizing,
and anti-fouling methods and products are all applications of Titania [6-7].
Characteristics of Titania or Titanium (IV) dioxide exhibit three polymorphic
lattice phases, Rutile, Anatase, and Brookite. The most thermodynamically stable phase
is Rutile because it has minimal electrostatic repulsive energy. Rutile is formed in a linear
structure that is tetragonal and two of the twelve edges are shared in the octahedron [8].
Anatase phase is also tetragonal and shares four edges per octahedron without corner
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oxygen sharing.

Brookite is unique with three shared edges per octahedron in an

orthorhombic composure. Zallen and Moret measured the optical absorption edge of
Brookite Titania and saw that its phase extends throughout the visible light range [9].
Brookite was observed to have a broad absorption edge in contrast to the steep absorption
edges of Anatase and Rutile. No evidence of a direct gap was observed in the evaluated
spectral range. It was proposed that Brookite phase Titania is an indirect-gap
semiconductor with an approximate bandgap of 1.9 eV [9]. In contrast, calculations using
the self-consistent orthogonalized linear-combination-of-atomic-orbitals method, Mo and
Ching, 1995 approximated a direct bandgap for Brookite [10]. Other researchers have
determined that all three phases of Titania have similar direct bandgap energies (~3.1 +
0.1 eV) [11]. Banerjee and colleagues report different bandgap values for each phase,
Anatase (3.2 eV), Rutile (3.02 eV), and Brookite (2.96 eV) [12]. Whether direct or
indirect, Brookite phase Titania exhibits the lowest bandgap energy.
Characteristics of a photocatalyst were described as its ability to simultaneously
adsorb two reactants [12]. Then efficiently absorb light (hv > Eg) to reduce and oxidize
the adsorbed reactants. In order to excite the electron (e-) from the valence band to the
conduction band producing an e--h+ pair, the absorbed light energy must be equal or
larger than the bandgap without being consumed. The produced hydroxyl radicals oxidize
holes in the cells walls / membranes allowing the contents to leak out and also be
degraded. Superoxide anions (.O2-) can enter the cells through the holes in the cell walls
and produce Reactive oxygen species (ROS), such as H2O2 molecules that will
decompose DNA via the Fenton Reaction.
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Ions such as Phosphate have a very high affinity for Titania and can significantly
decrease the photocatalytic activity. The substrate, ions, diluent, surface roughness,
hydrophilicity or hydrophobicity, morphology, particle size, surface area, and crystal
structure, absorption edge type, direct or indirect bandgap, bandgap size, number of
exposed active sites, are all factors that influence the amount of photocatalytic activity on
Titania [12].

1.2 Significance of Bacteria, Biofilm, and Overuse of Antibiotics
Significant overuse of broad spectrum antibiotics has escalated the emergence of
bacterial resistance. These Multi-Drug Resistant (MDR) bacterial infections increase the
morbidity and mortality of patients. Therefore, nosocomial infections of bacteria such as
Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli are expected to rise.
The CDC states that approximately 65% of infections are found in biofilms.
Currently, antibiotics provide a selective method of bacterial elimination, but are
losing the battle against emerging resistant pathogens. A rising problem consists of
bacteria sharing plasmids, crossing specie boundaries. In Brooklyn, New York three
hospitals isolated E. coli from UTIs that possessed 23-kb plasmid encoding Klebsiella
pneumonia carbapenemase type 2 (KPC-2) and increasingly containing the gene blaKPC-2
[13]. The gram-negative multi-drug-resistant (MDR) bacteria Acinetobacter baumannii
is ubiquitous and can be isolated from water, soil, animals, humans, and other
environmental sources [14]. It is aerobic and an opportunistic pathogen escalating
nosocomial outbreaks in intensive-care-units (ICU) and burn units [15] [16] [17]. The
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mechanisms which allow for such MDR in A. baumannii could be that they amass
quickly and exchange genetic information easily [16, 18]. Recently a clinical isolate of
that produced extended-spectrum β-lactamase but was carbapenem-susceptible, contained
more than 40 identified resistance genes [19]. This unique class of Gram-negative
bacteria may easily share genetic pools where prevalent clonal groups of A. baumannii
co-exist via horizontal gene transfer [16, 18, 20].

Clonal expansion may work

additionally to increase resistance [20].
Another method of resistance is chromosomal cassette transfer [21]. DNA damaging
antibiotics depress SOS-regulated polymerases via LexA cleavage inducing resistant
mutations [22]. SOS-independent response increased frameshift mutations when exposed
to β-lactam antibiotics [23]. A. baumannii contains an over-expressed efflux pump
affecting many type of antibiotics [24]. Sub-lethal levels of antibiotics induce
mutagenesis via reactive oxygen species (ROS). The bacteria remained sensitive to the
utilized antibiotic, but increased mutant strains that were resistant to other antibiotics
[25].
Another mechanism that bacteria use to protect themselves is by creating and
living in biofilms [26]. Bacteria change from planktonic to sessile existence through
attachment to surfaces. Generating a gooey matrix and signaling (quorum sensing (QS))
one another to proliferate into a microcolony, offers a selective advantage to increase
their survival rate. [27]. Other species of bacteria may join the colony due to QS signals
released into the environment. These chemical gradients allow for a diverse species to
coexist. Lastly, some cells escape from the colony and return to the planktonic state
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moving and landing in a different location to start the process of biofilm formation again.
Biofilms are ubiquitous and the CDC estimates that biofilms are involved in at least 65%
of all infections [28].
Reisner and colleagues determined that biofilm formation was significantly
dependent on growth medium composition [29]. Specific adhesion to

D-mannose

demonstrated direct binding of FimH type 1 pili which is serologically conserved
throughout Enterobacteriaceae [30]. EC and many other species of bacteria contain
hydrophilic fimbriae that attach to biotic and abiotic surfaces [31-32].
E. coli B was chosen as the model bacteria in this work was for the following
reasons. First, E. coli B contains the fimH gene, which codes for the hydrophilic FimH
subunit of type 1 pili conferring attachment to biotic and abiotic surfaces. QS in E. coli is
capable of binding to and responding to exogenous Acetylhomoserine lactone (AHL),
and regulate target gene expression

and adjust cellular functions to match the

environment [33].
When microorganisms attach to a surface and grow as biofilm, they become less
susceptible to antimicrobials than the same microbes in planktonic growth. Several
factors are responsible for biofilm resistance including restricted penetration of
antimicrobials into a biofilm, decreased growth rate, and expression of resistance genes
[34-36].
Exopolymer matrix of biofilms can restrict diffusion of drugs. Diffusion rate in a
biofilm is approximately 20 to 80 percent of that in free floating planktonic state [37].
The negatively charged exopolysaccharide is also effective against positively charged
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antibiotics retarding permeation [38-39]. Another biofilm-reduced susceptibility could be
contributed to the slower growing rate or non-growing status, or increased stress
responses of microbial cells in biofilm due to limited diffusion of oxygen, nutrients, or
starvation protecting the biofilm from environmental stresses [40] [41].
Different strategies [26] to prevent or eradicate bacteria biofilms include:
prevention of attachment or QS [42-45]. A super-hydrophilic surface with a contact angle
of <5o is used and may attract the hydrophilic heads of bacterial fimbriae to the surface
[46]. Hydroxyl radicals would successively attack the bacterial cell walls and membranes
through the photocatalytic activity of the UVA or visible light (VL) irradiated surface.
Titanium dioxide water structure at the TiO2/aqueous interface is significantly dependent
on the specific nature of the ions present in the diluent and the pH for optimized
photocatalytic activity.

1.3 Significance of Skin Cancer and Current Treatments
In the United States Skin cancer is the most common form of cancer with basal
cell and squamous cell carcinomas being the two highest common types. Malignant
Melanoma is highly dangerous among younger people. Exposure to ultraviolet (UV) light
or sunlight, or tanning beds, or other sources of man-made UV such as fingernail polish
curing with UV causes approximately 65%–90% of melanomas [47]. In the U.S. in 2006,
53,919 people were diagnosed with skin melanomas and 8,441 people in the United
States died from skin melanomas [48]. Protection from UV light will prevent most skin
cancers [47]. People living in areas of the earth that receive high levels of UV radiation
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are at higher risk developing skin cancer [49]. Skin cancer is an accumulative
phenomenon and is related to lifetime exposure to UV radiation. The time of day such as
midday presents a higher chance of cancer. Normal skin or in an existing mole can
becomes cancerous; Melanoma can develop anywhere on your body. Indicators of
Melanoma include moles with irregular borders and different colors, lesions on palms of
hands or feet, large multicolored spots with darker speckles, a mole that changes color,
size, or bleeds.
Exposure to photocatalytically activated Anatase phase Titanium dioxide resulted
in a dose-dependent decrease of cell-viability in goldfish cells [50]. With similar results,
another research group used TiO2 nanoparticles (DeGussa) that were 75% Rutile and
25% Anatase crystalline phase in free suspension [51].
In human hepatoma Bel-7402 cells, apoptosis induced by the photocatalytically
activated TiO2 nanoparticles was determined to be the primary mechanism of cell death
[52].

The small size with large surface area and unique characteristics of TiO2

nanoparticles may facilitate absorption and transport across the barriers of mammalian
epithelium (skin, lungs, and gut) followed with systemic entry to the circulatory system
to secondary target organs and may even cross the blood-brain barrier to reside in the
brain [53-54].
Opposing the above theory, Kiss and colleagues (2008) investigated the
possibility of TiO2 particles penetrating through the stratum corneum in human skin
xenografts onto nude mice [55].

The stratum corneum funtioned to keep the TiO2
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nannoparticles from traveling further through intact skin. Photocatalytically activated
Titania may prove to be a treatment modality for skin cancer.

1.4 Relevant Previous Research by Our Collaborators
The minimization of lattice defects and influennce of hydroxyl content were
evaaluated. Water-based Ambient Condition Sol (WACS) post-treated by a Solventbased Ambient Condition Sol (SACS) process in sec-butanol (sec-BuOH), processed
primarily Brookite phase Titania. A polar solvent, N-methylpyrrolidone (NMP), was used
to alter polymorphic Titania nanoparticles to increase photocatalytic activity by
extracting lattice hydroxyls and adorn nitrogen on the surface of the Titania
nanoparticles. The nanoparticles were well characterized and the photocatalytic activity
was evaluated via Methyl orange oxidative degradation by exposure to either a 182 Watt
UVA lamp or a 150 Watt Halogen lamp. Two types of polymorphic Titania were
produced, Br200 and BrNMP.

1.5 Relevant Previous Research by Our Lab
A free suspension assay was developed and evaluated Titania nanoparticles under
UVA (365 nm) exposure on bacteria. A working concentration of Titania in free
suspension was established. While the method is accurate and highly reproducible, it used
a lot of material, time, money, and labor. A preliminary coating study with Titania
suspended and mixed in the Binder was undertaken.
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Previous research was deficient in the following items. A complete death curve
was never identified. Only UVA (365 nm) provided useable data. Titania was mixed with
Binder provided by our collaborators. The method used, coated all sides of the crystal
lattice, and cells numbers were not significantly reduced in 30 minutes of UVA exposure.
A fast miniaturized assay was not created. Visible light exposure of Br200 and P25 in a
free suspension assay only gained a 3 log reduction difference after 8 hours of exposure.
BrNMP was not evaluated. From the above it is evident that the Specific Aims and
Objectives of my research are different and advance the knowledge of this line of
research.

1.6 Significance of This Research to the Scientific Community
The significance of the proposed research is to aid in the prevention of
transmission of bacteria in the nosocomial and community settings. Developing a suitable
coating for hospitals and long-term managed care facilities would enhance the patients’
lives by preventing bacterial infections that can easily cause death, and increase the
length of the patients’ lives. The surface coating must be safe, effective, inexpensive,
durable, and easy to install and care for. Therefore, two different types of polymorphic
Brookite will be evaluated under UVA and VIS light separately, comparing them to the
appropriate controls and commercial samples. Developing a sub-coating with the above
characteristics, that will enhance the photocatalytic activity of the Titania, for work under
VIS light irradiation in a timely manner. The success of this new research would
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significantly enhance the well-being of people’s lives in the nosocomial and community
settings.
Even more differently, examination of these Titania with coatings for cancer
treatments will be evaluated. Proving these novel methods and coatings work well would
help cancer patients have less scarring and deleterious effects from cancer treatment. This
new research would significantly enhance cancer patients’ lives. Therefore, this research
is different from prior work and has the possibility of significantly impacting the body of
Science and increasing the quality of life significantly for many people.
Current Status
We have the two types of polymorphic Brookite Titania graciously provided to us by
our collaborators, Dr. Lee and Dr. Kaewgun. Through prior evaluations with the free
suspension bioassay, we have a partial death curve and a working concentration with in
which to start our new and further developing research.

1.7 Research Objectives
Therefore my objectives for my research include the following:
•

Modify and miniaturize the free suspension assay

•

Adapt the modified and miniaturized assay for use with coatings

•

Develop a sub-coating for the Titania, and characterize it to confirm a match with
the original properties of the loose nanoparticles.
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•

Determine the death curve of each appropriate type of Titania under UVA in free
suspension

•

Determine the death curve of each appropriate type of Titania under VL in free
suspension

•

Evaluate the photocatalytic ability of free suspension Titania under UVA light on
Methyl Orange oxidative-degradation to verify activity in the new assay format

•

Evaluate the photocatalytic ability of free suspension Titania under VL light on
Methyl Orange oxidative-degradation to verify activity in the new assay format

•

Determine the death curve of each appropriate type of Titania under UVA on
novel sub-coating with Titania

•

Determine the death curve of each appropriate type of Titania under VL on novel
sub-coating with Titania

•

Evaluate the photocatalytic ability of sub-coating with appropriate Titania under
UVA light on Methyl Orange oxidative-degradation to verify activity

•

Evaluate the photocatalytic ability of sub-coating with appropriate Titania under
VL light on Methyl Orange oxidative-degradation to verify activity in the new
assay format

•

Based upon those results, choose the best candidate for evaluation of the most
active form of free suspension Titania on cancer cells in vitro as a feasibility proof
of concept model

11

•

Based upon those results, choose the best candidate for evaluation of a second
novel sub-coating containing the most active form of Titania on cancer cells in
vitro as a feasibility proof of concept model
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CHAPTER TWO
LITATURE REVIEW

2.1 Titania, Characteristics, Current Products, and Uses
Titania or Titanium dioxide (TiO2) degrades compounds through photo-oxidation
making it a versatile non-selective compound with photocatalytic properties. Titanium
dioxide exists in three different polymorphic lattice phases, Anatase, Brookite, and
Rutile. Rutile phase has minimal electrostatic repulsive energy, and is the most
thermodynamically stable due to its abridged in a linear structure with two of the twelve
edges shared in the octahedron [8]. Anatase phase shares four edges per octahedron
without corner oxygen sharing. Uniquely, Brookite phase is composed orthorhombically
with three shared edges per octahedron. Zallen and Moret measured the optical
absorption edge of Brookite Titania [9]. The optical absorption edge of Brookite phase
extends throughout the visible light range. Brookite was observed to have a broad
absorption edge in contrast to the steep absorption edges of Anatase and Rutile. No
evidence of a direct gap was observed in the evaluated spectral range. It was proposed
that Brookite phase Titania is an indirect-gap semiconductor with an approximate
bandgap of 1.9 eV [9]. In contrast, calculations using the self-consistent orthogonalized
linear-combination-of-atomic-orbitals method, Mo and Ching, 1995 approximated a
direct bandgap for Brookite [10]. Other researchers have determined that all three phases
of Titania have similar direct bandgap energies (~3.1 + 0.1 eV) [11]. Banerjee and
colleagues report different bandgap values for each phase, Anatase (3.2 eV), Rutile (3.02
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eV), and Brookite (2.96 eV) [12]. Whether direct or indirect, Brookite phase Titania
exhibits the lowest bandgap energy.
Characteristics of a photocatalyst were described as its ability to simultaneously
adsorb two reactants [12]. Then efficiently absorb light (hv > Eg) to reduce and oxidize
the adsorbed reactants. In order to excite the e- from the valence band to the conduction
band producing an e--h+ pair, the absorbed light energy must be equal or larger than the
bandgap without being consumed. The produced hydroxyl radicals oxidize holes in the
cells walls / membranes allowing the contents to leak out and also be degraded.
Superoxide anions (.O2-) eventually produce Reactive oxygen species (ROS), H2O2
molecules decomposing DNA via the Fenton Reaction.
Ions such as Phosphate have a very high affinity for the Titania and can
significantly decrease the photocatalytic activity. The substrate, ions, diluent, surface
roughness, hydrophilicity or hydrophobicity, morphology, particle size, surface area, and
crystal structure are factors that influence the amount of photocatalytic activity [12].
Titanium dioxide is a versatile compound that is used in many applications,
industries, materials, and products throughout the world. It is used in pigments due to it
extremely high refractive index of n = 2.7 [1]. The Huntsman Pigments Company,
(Billingham, England) produces Rutile phase pigments for architectural paints for use in
highly opaque surface coatings, powder coatings, plastics, inks, and paper applications.
Huntsman produces Anatase phase pigment for delustring synthetic fibers such as
polyester and optical brighteners in ceramics. Another company makes photovoltaic
solid-state hetero-junctions comprising a dense TiO2 film electrode as an electron
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conductor [2]. In a medical application, a high compressive strength (>2 MPa) titanium
oxide scaffold may be used in bone [3]. Hair dye, sun screens, and cosmetics are popular
Titania containing products [4]. Chemical vapor deposition using Anatase phase for selfcleaning, super hydrophilic, antimicrobial glass [5]. Photomineralization with air and
water purification, photoelectrodes as a hydrolysis catalyst, and photosterilization in
sterilizing, deodorizing, and anti-fouling methods and products [6-7].

2.2 Bacteria, Biofilm, and Overuse of Antibiotics
Significant overuse of broad spectrum antibiotics has escalated the emergence of
bacterial resistance. These Multi-Drug Resistant (MDR) bacterial infections increase the
morbidity and mortality of patients. Therefore, nosocomial infections of bacteria such as
Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli are expected to rise.
Currently, antibiotics provide a selective method of bacterial elimination, but are
losing the battle against emerging resistant pathogens. A rising problem consists of
bacteria sharing plasmids, crossing specie boundaries. In Brooklyn, New York three
hospitals isolated E. coli from UTIs that possessed 23-kb plasmid encoding Klebsiella
pneumonia carbapenemase type 2 (KPC-2) and increasingly containing the gene blaKPC-2
[13]. The gram-negative multi-drug-resistant (MDR) bacteria Acinetobacter baumannii
is ubiquitous and can be isolated from water, soil, animals, humans, and other
environmental sources [14]. It is aerobic and an opportunistic pathogen escalating
nosocomial outbreaks in intensive-care-units (ICU) and burn units [15] [16] [17]. The
mechanisms which allow for such MDR in A. baumannii could be that they amass
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quickly and exchange genetic information easily [16, 18]. Recently a clinical isolate of
that produced extended-spectrum β-lactamase but was carbapenem-susceptible, contained
more than 40 identified resistance genes [19]. This unique class of Gram-negative
bacteria may easily share genetic pools where prevalent clonal groups of A. baumannii
co-exist via horizontal gene transfer [16, 18, 20].

Clonal expansion may work

additionally to increase resistance [20].
Another method of resistance is chromosomal cassette transfer [21]. DNA
damaging antibiotics depress SOS-regulated polymerases via LexA cleavage inducing
resistant mutations [22]. SOS-independent response increased frameshift mutations when
exposed to β-lactam antibiotics [23]. A. baumannii contains an over-expressed efflux
pump affecting many type of antibiotics [24]. Sub-lethal levels of antibiotics induce
mutagenesis via reactive oxygen species (ROS). The bacteria remained sensitive to the
utilized antibiotic, but increased mutant strains that were resistant to other antibiotics
[25].
Another mechanism that bacteria use to protect themselves is by creating and
living in biofilms [26]. Bacteria change from planktonic to sessile existence through
attachment to surfaces. Generating a gooey matrix and signaling (quorum sensing (QS))
one another to proliferate into a microcolony, offers a selective advantage to increase
their survival rate. [27]. Other species of bacteria may join the colony due to QS signals
released into the environment. These chemical gradients allow for a diverse species to
coexist. Lastly, some cells escape from the colony and return to the planktonic state
moving and landing in a different location to start the process of biofilm formation again.

23

Biofilms are ubiquitous and the CDC estimates that biofilms are involved in at least 65%
of all infections [28].
Reisner and colleagues determined that biofilm formation was significantly
dependent on growth medium composition [29]. Specific adhesion to

D-mannose

demonstrated direct binding of FimH type 1 pili which is serologically conserved
throughout Enterobacteriaceae [30]. EC and many other species of bacteria contain
hydrophilic fimbriae that attach to biotic and abiotic surfaces [31-32].
E. coli B was chosen as the model bacteria in this work was for the following
reasons. First, E. coli B contains the fimH gene, which codes for the hydrophilic FimH
subunit of type 1 pili conferring attachment to biotic and abiotic surfaces. QS in E. coli is
capable of binding to and responding to exogenous Acetylhomoserine lactone (AHL),
and regulate target gene expression

and adjust cellular functions to match the

environment [33].
When microorganisms attach to a surface and grow as biofilm, they become less
susceptible to antimicrobials than the same microbes in planktonic growth. Several
factors are responsible for biofilm resistance including restricted penetration of
antimicrobials into a biofilm, decreased growth rate, and expression of resistance genes
[34-36].
Exopolymer matrix of biofilms can restrict diffusion of drugs. Diffusion rate in a
biofilm is approximately 20 to 80 percent of that in free floating planktonic state [37].
The negatively charged exopolysaccharide is also effective against positively charged
antibiotics retarding permeation [38-39]. Another biofilm-reduced susceptibility could be
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contributed to the slower growing rate or non-growing status, or increased stress
responses of microbial cells in biofilm due to limited diffusion of oxygen, nutrients, or
starvation protecting the biofilm from environmental stresses [40] [41].
Different strategies [26] to prevent or eradicate bacteria biofilms include:
prevention of attachment or QS [42-45]. A super-hydrophilic surface with a contact angle
of <5o is used and may attract the hydrophilic heads of bacterial fimbriae to the surface
[46]. Hydroxyl radicals would successively attack the bacterial cell walls and membranes
through the photocatalytic activity of the UVA or visible light (VL) irradiated surface. As
Titanium dioxide water structure at the TiO2/aqueous interface is significantly dependent
on the specific nature of the ions present in the diluent and the pH for optimized
photocatalytic activity.

2.3 Skin Cancer
In the United States Skin cancer is the most common form of cancer with basal
cell and squamous cell carcinomas being the two highest common types. Melanoma is
highly dangerous among younger people. Exposure to ultraviolet (UV) light or sunlight,
or tanning beds, or other sources of man-made UV such as fingernail polish curing with
UV causes approximately 65%–90% of melanomas [47]. In the U.S. in 2006, 53,919
people were diagnosed with skin melanomas and 8,441 people in the United States died
from skin melanomas [48]. Protection from UV light will prevent most skin cancers [47].
People living in areas of the earth that receive high levels of UV radiation are at higher
risk developing skin cancer [49]. Skin cancer is an accumulative phenomenon and is
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related to lifetime exposure to UV radiation. The time of day such as midday presents a
higher chance of cancer. Normal skin or in an existing mole can becomes cancerous;
Melanoma can develop anywhere on your body. Indicators of Melanoma include moles
with irregular borders and different colors, lesions on palms of hands or feet, large
multicolored spots with darker speckles, a mole that changes color, size, or bleeds.
Skin Cancer Research
Exposure to photocatalytically activated Anatase phase Titanium dioxide resulted
in a dose-dependent decrease of cell-viability in goldfish cells [50]. With similar results,
another research group used TiO2 nanoparticles (DeGussa) that were 75% Rutile and
25% Anatase crystalline phase in free suspension [51].
In human hepatoma Bel-7402 cells, apoptosis induced by the photocatalytically
activated TiO2 nanoparticles was determined to be the primary mechanism of cell death
[52].

The small size with large surface area and unique characteristics of TiO2

nanoparticles may facilitate absorption and transport across the barriers of mammalian
epithelium (skin, lungs, and gut) followed with systemic entry to the circulatory system
to secondary target organs and may even cross the blood-brain barrier to reside in the
brain [53-54].
Opposing the above theory, Kiss and colleagues (2008) investigated the
possibility of TiO2 particles penetrating through the stratum corneum in human skin
xenografts onto nude mice [55].

The stratum corneum funtioned to keep the TiO2

nannoparticles from traveling further through the intact skin. Titania may prove to be a
treatment modality for skin cancer.
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CHAPTER THREE
DEVELOPMENT, CHARACTERIZATION, AND PHOTOCATALYTIC ACTIVITY
OF LIGHT ACTIVATED POLYMORPHIC BROOKITE TITANIA ENHANCED VIA
NOVEL SUB-COATTINGS ON Escherichia coli

(As a manuscript formatted for submission to the Journal of Nanobiotechnology)

3.1 Abstract
Nosocomial infections are rising due to bacterial adaptation combined with
overuse of broad spectrum antibiotics which significantly increased emergence of
resistant pathogens. Because about sixty-five percent of all bacterial infections are
biofilm associated, an inexpensive, durable, safe, visible-light activated, and nonselective antimicrobial surface coating is ideal. Titanium dioxide, a versatile nonselective compound with photocatalytic properties, degrades compounds through photooxidation. Titanium dioxide exists in three lattice phases, Anatase, Brookite, and Rutile,
with Anatase used extensively. Without doping or close atomic association with another
specific atom causing band-gap narrowing, Titanium dioxide is active under long wave
ultraviolet light (365 nm) and not visible light. Studies incorporating doping of atoms into
the crystal lattice structure can only be performed at temperatures higher than the phase
transition temperature for Brookite, causing Anatase or Rutile lattice configurations. In
order to maintain the Brookite phase of the Titanium dioxide, this study evaluated a novel
super hydrophilic polyelectrolyte sub-coating. Room temperature deposition maintained
the Brookite lattice phase and provided atomic surface associations between the sub-
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coating and the Titania. The sub-coating contained Nitrogen and Sulfur molecules. With
their surface associations to the Titania, it was proposed to narrow the band-gap, causing
visible-light photocatalytic activity. In conjunction with the sub-coating, two types of
polymorphic Brookite phase Titania were evaluated, Br200 and BrNMP.
PDDA/PSS sub-coatings were successfully attached to glass cover-slips in a 25
layer-by-layer room temperature liquid deposition method. Each type of Titania
evaluated was attached to the PDDA/PSS sub-coated cover-slips by room temperature
liquid phase deposition via XPS analysis. Appropriate molecules of O 1s, N 1s, S 2P and
Ti 2p were found on the surface of the cover-slips. XRD analysis determined that
predominantly Brookite phase with some Anatase phase and a small amount of Rutile
phase Titania lattice structures remained on the surface of the cover-slips matching peaks
with the powder Titania samples. The PDDA/PSS sub-coating was found to be
photocatalytically active under visible light on Methyl orange degradation and had
bactericidal activity on E. coli B. Visible-light photocatalytically activated super
hydrophilic polyelectrolyte sub-coating with vlp7000, Br200, or BrNMP Titania killed all
E. coli B in 40, 8, or 30 minutes, respectively, or with binder sub-coating plus each type
of Titania eliminated all E. coli B in 60, 50, or 50 minutes, respectively.
Light intensity, wavelength, amount of surface area, size of each crystallite,
surface material characteristics, pH, band gap, efficiency of hole-electron recombination,
amount of dissolved oxygen, broad absorption edge (indirect bandgap) versus sharp
absorption edge (direct bandgap), number of available active surface sites, and bacterial
load affect efficiency of photo-oxidation. The super-hydrophilic nature of the
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polyelectrolyte-Titania coating attracts and enhances photo-oxidative activity due to
bacterial adherence via hydrophilic fimbriae that attach to biotic and abiotic surfaces.
Br200 demonstrated a stable working pH range including pH3 to 4. The 5-8nm diameter
crystallite size range provides a large surface area, changing the characteristics from a
monolithic nature to Nitrogen and Sulfur molecules being able to associate with the
crystal lattice structures on the surface of each surface crystallite, and significantly
increasing target contact probability. We suggest that the association of the Nitrogen and
Sulfur molecules on the sub-coating interact with the surface of the lattice structures on
each nanoparticle surface, enhancing visible light photo activity by narrowing the bandgap and slowing the electron/hole recombination. Br200 and BrNMP Titania on the
polyelectrolyte sub-coating provided superior photo-oxidative activity on both Methyl
orange degradation and bacterial decomposition compared to the commercial P25 and
vlp7000 Titania, or binder sub-coating with Titania. Further characterization and
evaluation of these PDDA/PSS sub-coatings with Br200 or BrNMP are warranted.
Furthermore, the Br200 may have been more photocatalytically active than the BrNMP in
association with the sub-coatings on E. coli B. This phenomenon may be caused by the
low manufacturing and calcination temperatures of BrNMP. Some charred NMP residue
may have remained on the Titania surface and blocked some of the photoactive sites and
aided in electron/hole recombination. Also the bacteria may not have been as attracted to
the residue covered surface of BrNMP. These novel polyelectrolyte-Br200 or
polyelectrolyte-BrNMP non-selective Titania coatings would provide a low cost, visiblelight active, safe, and effective non-selective method to aid in preventing transmission of
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bacterial infections and in prevention of biofilm formation in the nosocomial and
community settings.

3.2 Introduction
Worldwide exploitation of broad spectrum antibiotics significantly increased
emergence of bacterial resistance. Bacterial infections increase the morbidity and
mortality of patients in war zones, acute or long-term care hospitals. As the world
population increases and people travel further and live longer, they will require more
hospital and long-term managed care. Therefore, nosocomial infections of bacteria such
as Escherichia coli are expected to rise.
Currently, antibiotics provide a selective method of bacterial elimination, but are
losing the battle against emerging resistant pathogens. A rising problem consists of
bacteria sharing plasmids, crossing specie boundaries. Hospitals isolated E. coli from
UTIs that possessed 23-kb plasmid encoding Klebsiella pneumonia carbapenemase type 2
(KPC-2) and increasingly containing the gene blaKPC-2 [13]. The gram-negative multidrug-resistant (MDR) bacteria Acinetobacter baumannii is ubiquitous and can be isolated
from water, soil, animals, humans, and other environmental sources [14]. It is aerobic and
an opportunistic pathogen escalating nosocomial outbreaks in intensive-care-units (ICU)
and burn units [15] [16] [17]. The mechanisms which allow for such MDR in A.
baumannii could be that they amass quickly and exchange genetic information easily [16,
18]. A. baumannii extended-spectrum β-lactamase isolates containing more than 40
identified resistance genes have been identified [19]. This unique class of Gram-negative
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bacteria may easily share genetic pools where prevalent clonal groups of A. baumannii
co-exist via horizontal gene transfer [16, 18, 20].

Clonal expansion may work

additionally to increase resistance [20].
Another method of resistance is chromosomal cassette transfer. Staphylococcus
aureus contains the staphylococcal chromosomal cassette (SCCmec), in which the gene
mecA encodes for PBP2a causing low binding affinity to β-lactam antibiotics thus
rendering them ineffective on cell wall synthesis disruption [21]. DNA damaging
antibiotics such as ciprofloxacin depresses SOS-regulated polymerases via LexA
cleavage inducing resistant mutations [22]. SOS-independent response by induction of
DinB increased frameshift mutations when exposed to β-lactam antibiotics [23]. A.
baumannii contains an over-expressed efflux pump affecting fluoroquinolones,
tetracyclines, aminoglycosides, erythromycin, cefotaxime, and trimethoprim [24].
Kohanski and colleagues recently identified an increase in reactive oxygen species (ROS)
due to exposure to sub-lethal levels of antibiotics induce mutagenesis. The bacteria
remained sensitive to the utilized antibiotic, but increased mutant strains that were
resistant to other antibiotics [25].
Another mechanism that bacteria use to protect themselves is by creating and
living in biofilms. Costerton and Stewart (2006) put together a theory of how biofilms
develop [26]. Within natural, medical, and engineered environments, free-swimming
(planktonic) bacteria land on a surface, aggregate and affix to living and abiotic surfaces,
causing the bacteria to change from its planktonic state to a sessile existence. Generating
a gooey matrix and signaling (quorum sensing) one another to proliferate into a
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microcolony, offers a selective advantage to increase their survival rate. Although not
adhered directly to the surface, some bacteria in the matrix may grow a polysaccharide
capsule for protection, remaining dormant until favorable environmental conditions arise
[27]. Other species of bacteria may join the colony due to chemical auto-induced signals
released into the environment. These chemical gradients allow different metabolic states
and diverse species to coexist. Lastly, some cells escape from the colony and return to the
planktonic state moving and landing in a different location to start the process of biofilm
formation again. Biofilms are ubiquitous and implicated in several infectious processes
including nosocomial infections such as indwelling devices and chronic infections. The
CDC estimates that biofilms are involved in at least 65% of all infections [28].
Reisner and colleagues determined that biofilm formation was significantly
dependent on growth medium composition, rather than the association between
pathogenic E. coli, increased biofilm formation, to commensal E. coli K-12 strains that
normally reside within the mucus layer without colonizing the epithelium [29]. Krogfelt
and researchers (1990) used a carrier protein attached to D-mannose to demonstrate direct
binding of FimH the mannose-specific adhesion. FimH was visualized by electron
microscopy. The FimH adhesin of the type 1 pilus is serologically conserved throughout
Enterobacteriaceae [30]. Electron Microscopy depicted a 16 nm fibrillar tip structure
joined end to end on the pilus rod with structural design matching the FimG-FimH
complex. . EC and many other species of bacteria contain hydrophilic fimbriae that
attach to biotic and abiotic surfaces [31-32].
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E. coli B was chosen as the model bacteria in this work was for the following
reasons. First, E. coli B contains the fimH gene, which codes for the hydrophilic FimH
subunit of type 1 pili conferring attachment to biotic and abiotic surfaces. In the
Vandemaele study, greater than ninety nine percent homology was indicated among
strains from either bovine (B), avian (A), or porcine (P) species. Of the 24 strains tested,
all contained the fimH gene except strain P3. Secondly, Quorum Sensing was examined.
E. coli contains the signal receptor protein SdiA of the luxR family. The SdiA receptor
protein is capable of binding to and responding to exogenous AHLs, but not producing
them, therefore regulating target gene expression [33]. SdiA also responds to endogenous
indole, allowing the bacteria to adjust cellular functions correctly in the biofilm
environment [56]. The signal generating enzyme was found to be a LuxS homologue
producing AI-2.
When microorganisms attach to a surface and grow as biofilm, they become less
susceptible to antimicrobials than the same microbes in planktonic growth. Several
factors are responsible for biofilm resistance including restricted penetration of
antimicrobials into a biofilm, decreased growth rate, and expression of resistance genes
[34-36].
Biofilms are enclosed in a self-produced exopolymer matrix that can restrict
simple diffusion of drugs. Diffusion rate in a biofilm is approximately 20 to 80 percent of
that in free floating planktonic state [37]. The negatively charged exopolysaccharide is
also effective against positively charged antibiotics, e.g. aminoglycoside, retarding their
permeation [38-39]. Another biofilm-reduced susceptibility could be contributed to the
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slower growing rate or non-growing status of microbial cells in biofilm due to limited
diffusion of oxygen, nutrients, or starvation. Slow growing or starved microorganisms are
less susceptible to the action of antimicrobials [41]. There may also be increased stress
responses which result in physiological changes that help protect the biofilm from
environmental stresses [40].
Different strategies [26] to prevent or eradicate bacteria include: prevention of
attachment by molecules through surface coatings that block adhesion via repressing
expression of genes involved in adhesion and matrix production. Use signal inhibitors or
within a biofilm, or some type of signal or chemical to cause release of cells back to their
more susceptible planktonic state for exposure to antibodies and other antibiotics.
Antibiofilm therapies based on incorporation of antibiotics into the medical materials
have been reported [42-45]. Due to these many avenues of bacterial resistance towards
antibiotics and through biofilm formation to enhance protection, a different approach to
killing bacteria is warranted, especially in the nosocomial settings. A non-selective, safe,
durable, controllable, coating that would kill bacteria and prevent biofilm formation
should be investigated. One promising compound is Titanium dioxide, however alone
requires photoactivation via long range ultra violet light which is not safe over time to
humans. Exposure to long range ultra violet light can cause cancer in humans. Therefore,
altering the Titania, or associating the Titania with something to cause it to be
photocatalytically active in a coating format in visible light is investigated in this work.
Titania or Titanium dioxide (TiO2), is a versatile non-selective compound with
photocatalytic properties, degrades compounds through photo-oxidation. Titanium
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dioxide exists in three different polymorphic lattice phases, Anatase, Brookite, and
Rutile. Rutile phase is the most thermodynamically stable due to its minimal electrostatic
repulsive energy; it is abridged in a linear structure with two of the twelve edges of the
octahedron are shared [8]. Anatase phase shares four edges per octahedron without corner
oxygen sharing. Uniquely, Brookite phase is composed orthorhombically with three
shared edges per octahedron. Zallen and Moret measured the optical absorption edge of
Brookite Titania [9]. Extending throughout the visible light range, Brookite was observed
to have a broad absorption edge in contrast to the steep absorption edges of Anatase and
Rutile. In the evaluated spectral range, no evidence of a direct gap was observed. They
propose the Brookite phase Titania is an indirect-gap semiconductor with an approximate
bandgap of 1.9 eV [9]. In contrast, calculations using the self-consistent orthogonalized
linear-combination-of-atomic-orbitals method, Mo and Ching, 1995 approximated a
direct bandgap for Brookite [10]. Other researchers have determined that all three phases
of Titania have similar direct bandgap energies (~3.1 + 0.1 eV) [11]. Banerjee and
colleagues report the bandgap values for each phase is Anatase (3.2 eV), Rutile (3.02
eV), and Brookite (2.96 eV) [12]. Whether direct or indirect, Brookite phase Titania
exhibits the lowest bandgap energy.
Chang and colleagues concluded that the optimal experimental conditions on
degradation of salicylic acid were irradiation with intensity of 2.9mWcm−2 on at
concentration of 250mgL−1 by both agitation and aeration processes (dissolved oxygen
level = 8.2 mg O2 L−1) at pH 5 [57] achieving optimal hydroxyl radical yield of 5.1×10−17
M. The pH, dissolved oxygen content, and irradiation intensity are important factors to
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consider. Also the rate of recombination of hole–electron pairs is within nanoseconds
[58-59]. Additives such as Pt, Pd and Au may improve the photocatalytic efficiency of
TiO2 by slowing down the recombination of the hole-electron pair. Plus, a single photon
can activate two oxygen molecules [58]. All of these parameters affect the photocatalytic
efficiency of TiO2.
Banerjee’s work used and Atomic Force Microscope (AFM) to visualize the
antimicrobial photocatalytic activity of photo-activated Titania on bacteria [12]. They
described the characteristics of a photocatalyst as its ability to simultaneously adsorb two
reactants. Then efficiently adsorb light (hv > Eg) to reduce and oxidize the adsorbed
reactants. The adsorbed light energy must be enough to excite the e- from the valence
band to the conduction band producing an e--h+ pair. In the presence of water and
dissolved oxygen (H2O/O2), the positive holes oxidize water splitting it into .OH and H+.
The dissolved oxygen is reduced by the photo electron of the conduction band, generating
superoxide anions (.O2-). H+ combines with the (.O2-) generating a hydroperoxyl radical,
eventually producing a reactive oxygen species (ROS) H2O2 molecule. The photo
induced ROS hydroxyl radical and hydrogen peroxide cause biocidal catalysis by
penetrating cell walls and cutting DNA strands. The super oxide anion can enter the cell
after oxidizing holes are made. Once inside, hydrogen peroxide and the super oxide anion
may become hydroxyl radical precursors. Once inside the cell wall (Fe2+) may activate
hydrogen peroxide via the Fenton reaction producing more damaging hydroxyl radicals.

Fe+2 + H2O2 → OH• + OH-1 + Fe+3
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After the photocatalytic source is turned off, residual hydrogen peroxide within the cell
would interact with the iron compounds generating additional hydroxyls also through the
Fenton reaction. There is a second reaction pathway forming additional hydroxyl
radicals. The Haber-Weiss iron-catalyzed reaction occurs when both H2O2 and superoxide
ion are present [60-61].

Fe+3 + O2- → Fe+2 + O2
Fe+2 + H2O2 → Fe+3 + OH- + OH•.
Because the outer surface of the cell is the initial target of these reactive oxygen species
(ROS), the chemical arrangements and rigidity of the each cell’s surface structure will
determine the effectiveness of the photocatalytic activity of each type of Titania.
The efficiency of the photocatalytic activity of Titania is also dependent on the
surrounding environment. Phosphate ions from Phosphate Buffered Saline have a very
high affinity for the Titania. Phosphate ions bind to the substrate surface causing the
isoelectric point of the TiO2/aqueous interface to significantly shift downward to pH2.0
and increasing the 3400cm-1 peak-intensity measured by vibrational sum-frequency
spectroscopy (VSFS). [62]. The isoelectric point was ~5.5 in the presence of Cl ions.
However, the Langmuir binding constant of phosphate onto TiO2 at pH 2.3 is (3.8 + 0.8)
x 104 dm3 mol-1 [63]. Adsorption kinetics depicting fast adsorption with very slow release
confirmed that phosphate binds in a bidentate manner to Ti(IV) ions at the TiO2 surface
[63].
In commercial applications, hydrophobicity or hydrophilicity characteristics of a
surface is important. A super-hydrophilic surface with a contact angle of <5o is used
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commercially in antifogging and antifouling products and in self cleaning products [46].
The hydrophilicity of the surface could attract the hydrophilic heads of bacterial fimbriae.
The fimbriae would attach to the surface where the hydroxyl radicals would successively
attack the bacterial cell walls and membranes through the photocatalytic activity of the
UVA or visible light (VL) irradiated surface. As Titanium dioxide water structure at the
TiO2/aqueous interface is significantly dependent on the specific nature of the ions
present in the diluent and the pH for optimized photocatalytic activity.
The type of coating chosen was made layer-by-layer and contained superhydrophilic surface characteristics. One component of the sub-coating, Poly(4styrenesulfonic acid) solution (PSS) (~75,000 Mw, 18%wt. in H2O, Sigma Aldrich, St.
Louis, MO) has excellent film-forming and coating capabilities along with good
conductive properties throughout an expansive range of relative humidity. The PSS
polyelectrolyte is electroconductive and is used for antistatic resin in electrographic and
electrophotographic substrates. It strongly interacts with electropositive active sites, and
produces polyanions when it is dissolved in water. Due to the polyanionic nature of PSS,
it has some tendency to also adsorb at the (100) crystal planes, but preferentially adsorbs
to the {111) crystal planes of Brookite [64]. Charge and steric stabilization decrease
coagulation effects in colloidal particles by these polyelectrolyte films. The second
component of the sub-coating was Poly(diallyldimethylammonium chloride) solution
(PDDA) (average Mw 200,000-350,000, 20 wt. % in H2O, Sigma Aldrich, St. Louis,
MO) a polyelectrolyte, PDDA, produces polycations when it is dissolved in water. It
strongly interacts with electronegative active sites. PDDA contains Nitrogen molecules.
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This work investigated two types of Brookite phase Titania, Br200 and BrNMP
on a pH dependent polyelectrolyte sub-coating. They with be evaluated under UVA 365
nm and Visible Light (VL) irradiation on Methyl orange (MO) photo-oxidation
degradation. The hydrophilicity, surface chemical analysis via X-ray Photoelectron
Spectroscopy (XPS), and X-ray Diffraction (XRD) of the Titania coatings will be
characterized. The Titania coatings will be evaluated for the photo-oxidative biocidal
effectiveness on Escherichia coli B.

3.3 Results
The chemical analyses of the PDDA/PSS (P) sub-coating surfaces with or without
Titania nanoparticles and nanoparticle coatings confirm the presence of the sub-coating
molecules and Titania on the surface (Table 1). XPS spectra graphs of P or B subcoating with and without Br200, P25, BrNMP, vlp7000, Anatase, or vlp7001 are depicted
in Appendix B. Surface elemental chemical analysis numerical results are exhibited in
Table 1.
The x-ray diffraction spectra of the glass cover slips with either P or Binder (B)
sub-coatings with or without TiO2 nanoparticle coatings are depicted in Figures 2 and 3,
respectively. The spectra graphs acquired were confirmed by comparison with the
original spectra graphs from the nanoparticle powders that were used to make the
coatings [65-66]. Kaewgun and colleagues reported considerably small (6-8mm)
crystallite sized particles of their prepared Titania broadened the XRD peaks and
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calculated phase composition of TiO2 from XRD data.

The Br200 (WACS-200)

calculated phase composition was 45 wt% Anatase, 53 wt% Brookite, and 2 wt% Rutile.
The P and B sub-coatings were different in surface hydrophilicity characteristics
shown in Figure 4. The P coatings with or without various Titania depicted superhydrophilicity as the 10 µL drop of nanopure water instantly flattened out and
disappeared from view with the naked eye. All P sub-coatings exhibited a contact angle
measurement of < 1o. In contrast the B sub-coatings with or without various Titania
displayed strong hydrophobic characteristics as the 10 µL drop of 18Ω nanopure water
remained rounded. The B sub-coating alone exhibited a contact angle of 62.5o, B+P25
51.5o, B+Br200 52.5o, B+BrNMP 67.5o, and B+vlp7000 at 105o indicating that the B subcoating is a material significantly more hydrophobic than the P sub-coating. For
comparison, the hydrophilicity contact angle results are located in Table 3.
Significance of difference was evaluated with a student T-Test with an alpha of
0.05. All P Sub-Coatings with or without all Types of Titania compared to all P Subcoatings with or without all Types of Titania at an alpha of 0.05 were not significantly
different from each other (p=0.35). P Sub-Coating with or without all types of Titania are
significantly different at an alpha of 0.05 from all B Sub-Coatings with or without all
types of Titania with a range of p values from 2.36 x 10-5 to 6.93 x 10-6. All B SubCoatings with or without all Types of Titania compared to all B Sub-coatings with or
without all Types of Titania at an alpha of 0.05 were all significantly different from each
other (p=0.016 to 3.15 x 10-6).
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The statistics of Figures 9 and 10 results were determined using a student T-Test
with alpha equal to 0.05. E. coli B in PBS pH 7.4 or water at pH 7.4 exposed to UV light
in the absence or presence of TiO2 P-25 or TiO2 Brookite did not significantly reduce the
bacterial population in 120 minutes. In contrast, E. coli B in water at pH 4.0 exposed to
UV in the presence of TiO2 P-25 and TiO2 Brookite had a significant seven log drop in
120 (p=0.004) or 30 (p=0.001) minutes, respectively. E. coli B in the absence of TiO2 in
water at pH 4.0 depicted no significant reduction of the bacterial population in 120
minutes. The pH of the water at 120 minutes dropped from pH 7.4 to pH 6.0, while the
water beginning at pH 4.0 remained at pH 4.0 (+ 0.2) throughout 120 minutes.
The earlier version of the Free Suspension Bioassay [67], was on a large scale
format. It is good and accurate, but used large amounts of materials, was labor intensive,
and only one test variable could be evaluated at a time. The assay was miniaturized with
the option of two different assays in combination with a third. Dilution curves of E. coli
B (n=8) were evaluated. Based on the results, the LIVE/DEAD® BacLight™ Bacterial
Viability Kit (Molecular Probes®, Invitrogen™,USA) was found to be linear in the range
of 1 x 103 to 1 x 108 CFU/mL in the presence of 1 mg/mL Titania. The second assay
evaluated was the BacTiter-Glo™ Microbial Cell Viability Assay (Promega, Madison,
WI). Based on the results, the BacTiter-Glo™ Microbial Cell Viability Assay was found
to be linear in the range of 1 x 102 to 1 x 107 CFU/mL in the presence of 1 mg/mL
Titania.
The six well – six mL volume free suspension assay was miniaturized to a 24 well
format using a 1 mL volume assay. Many testing variables were tested at the same time
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under this new assay format. An optically clear film was used to prevent evaporation
during testing. After testing, 100 µL aliquots (n=4) from each sample well was dispensed
into a 96 well black or white plate for fluorescence or luminescence assay, respectively.
The 24 well testing assay in combination with either the fluorescent LIVE/DEAD®
BacLight™ Bacterial Viability Kit or the luminescent BacTiter-Glo™ Microbial Cell
Viability Assay provided excellent results after subtracting the background. Although,
greater than the suggested cell concentration or greater than the suggested Titania
concentration of 1 mg/mL gave erroneous or non-linear results with either assay.
The UVA generated photocatalytic activities of P25, Br200, or BrNMP Titania
powder (1mg TiO2 / 1 mL) were evaluated by MO oxidative degradation as shown in
Figure 5. BrNMP and Br200 on P sub-coating completed the MO degradation in 10 and
14 h, respectively. BrNMP and Br200 on B sub-coating completed the MO degradation
in 18 and 22 h, respectively. The commercial P25 on P sub-coat attained approximately
80% degradation at 26 h and the P25 on B sub-coat achieved about 43% MO degradation
at 26 h. The sub-coatings alone did not have much effect on MO degradation. MO alone
did not degrade and remained at 0%.
The Visible Light generated photocatalytic activities of the P or B sub-coatings
alone or with P25, Br200, or BrNMP Titania coatings (2 mg TiO2 / 22 mm diameter
cover slip) were evaluated by MO oxidative degradation as shown in Figure 6. Titania
coated onto the P sub-coat degraded the MO significantly faster than its counterpart on B
sub-coating. Br200 and BrNMP on P sub-coating completed the MO degradation in 1214 h. Br200 and BrNMP on B sub-coating completed the MO degradation in 16-18 h and
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20 h, respectively. The commercial vlp7000 on P sub-coat attained approximately 95%
degradation at 26 h and on B sub-coat it achieved about 55% MO degradation at 26 h.
The sub-coatings alone had little effect on MO degradation. MO alone did not degrade
and remained at 0%.
The UVA generated photocatalytic activities of the P or B sub-coatings alone or
with P25, Br200, or BrNMP Titania coatings (2mg TiO2 / 38mm2 cover slip) were
evaluated by MO oxidative degradation as shown in Figure 5. All Titania coated onto the
P sub-coat degraded the MO significantly faster than its counterpart on B sub-coating.
BrNMP and Br200 on P sub-coating completed the MO degradation in 10 and 14 h,
respectively. BrNMP and Br200 on B sub-coating completed the MO degradation in 18
and 22 h, respectively. The commercial P25 on P sub-coat attained approximately 80%
degradation at 26 h and the P25 on B sub-coat achieved about 43% MO degradation at 26
h. The sub-coatings alone did not have much effect on MO degradation. MO alone did
not degrade and remained at 0%. Statistics were determined using a student T-Test with
alpha equal to 0.05. P or B Sub-Coating with MO (20 µM) in water at pH 4.0 exposed to
UV light (365nm) with a (363-364 µW/cm2) intensity in with or without P- P-25 26+ h
and P-Br200 14 h, or P-BrNMP 10 h, B- P-25 28+ h and B-Br200 22 h, or B-BrNMP 18
h oxidative degradation of MO. Br200 and BrNMP were significantly different from 2 h 26 h (p= 0.02 – 0.005); P25 was significantly different from16 h-28 h (0.044 – 0.032).
MO alone or on P or B- Sub-Coating was not significantly different throughout the 26 h
evaluated (p=0.35).
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The Visible Light generated photocatalytic activities of the P or B sub-coatings
alone or with P25, Br200, or BrNMP Titania coatings (2 mg TiO2 / 22 mm diameter
cover slip) were evaluated by MO oxidative degradation as shown in Figure 6. Titania
coated onto the P sub-coat degraded the MO significantly faster than its counterpart on B
sub-coating. Br200 and BrNMP on P sub-coating completed the MO degradation in 1214 h. Br200 and BrNMP on B sub-coating completed the MO degradation in 16-18 h and
20 h, respectively. The commercial vlp7000 on P sub-coat attained approximately 95%
degradation at 26 h and on B sub-coat it achieved about 55% MO degradation at 26 h.
The sub-coatings alone had little effect on MO degradation. MO alone did not degrade
and remained at 0%. Percent survival of E. coli B (EC) CFU/mL with and without VLP
7000, Br200, and BrNMP Titania on B Sub-Coating exposed to a cool white 8 Watt bulb
for either 0, 1, 2, 4, 6, 8, 10, 20, 30, 40, 50, or 60 minutes or the dark for 0, 30, or 60
minutes. (Error bars may be too small to see.)
Student T-Test indicated significant difference at an alpha of 0.05 between EC at
0 min to vlp7000, not significantly different at 0 or 10 min VL or 30 – 60 min D;
significantly different at 20 – 60 min VL (p= 0.005 – 0.001); between EC at 0 min to
Br200, not significantly different at 0, 2, 4, or 6, min VL or 30 – 60 min D (p= 0.3 – 0.2),
but significantly different at 8 – 60 min VL (p= 0.01 – 0.0002); and between EC at 0 min
to BrNMP, not significantly different at 0 min VL or 30 – 60 min D, but significantly
different at 10 – 60 min VL (p= 0.04 – 0.0002).
Preliminary studies were performed with Titania in modified, miniaturized free
suspension assays to determine a starting concentration of Titania for the coating studies.
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Dilution curves indicate linear results with minimal background in the 103 to 108
CFU/mL range using the Live/Dead® BacLight™ Bacterial Viability fluorescent based
Assay (L-7012, Molecular Probes, Eugene, OR) as shown in Figure 7.
Evaluation of the second assay dilution curve results indicate linearity with minimal
background in the 102 to 107 CFU/mL range using the Luminescent Assay Bac TiterGlo™ Microbial Cell Viability Assay (Promega: Madison, WI, USA) depicted in Figure
8.
Effects of UVA activated P25, Br200 and BrNMP Titania 1 mg/mL using the
miniaturized free suspension on E. coli B (EC) with the BacLight ™Assay over a 2 h
time period were evaluated (Figure 12). Results indicated that Br200 yielded an 8 log
drop in 30 minutes. BrNMP and P25 required 2 h to yield the 8 log drop. P25 in the dark
incurred an approximate 0.5 log drop during the 2 h, while Br200, BrNMP, and EC in
both UVA and dark remained the same.
Evaluation of the lower count (1 x 104) bacteria using either the Spiral Plater or
manual cell spreading yielded a 4 log drop in 60 or 90 seconds with P25 and Br200,
respectively (Figure 13). EC in both UV and Dark along with P25 and Br200 in the dark
results yielded the same as time zero. Student T-Test indicated significant difference at an
alpha of 0.05 between EC at 0 sec to P25, not significantly different at 0, or 90-120 sec in
the dark, but significantly different at 30 – 120 sec in UVA (p= 0.004 – 0.002); between
EC at 0 min sec to Br200, not significantly different at 0 min UVA or 90 - 120 sec D or
at 30 sec in UVA; but significantly different at 60 – 120 sec in UVA (p= 0.006 – 0.002).
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The effects of visible light (VL) activated Br200, BrNMP, or vlp7000 Titania
nanoparticles on EC were evaluated as shown in Figure 14. Br200 results yielded a 4 log
drop in EC within 30 minutes; vlp7000 completed the 4 log drop in 60 minutes while
BrNMP results yielded a ~2.5 log drop in 60 minutes. EC under light or in the dark,
Br200, BrNMP, and vlp7000 with EC cultures in the dark remained viable.
The results of exposing free suspension Titania nanoparticles (VLP 7000, Br200,
and BrNMP) to visible light using a fluorescent 8 Watt cool white bulb at 100 µW/cm2
intensity on E. coli B for 0, 10, 20, 30, 40, 50, or 60 minutes yielded the results shown in
Figure X. Dark measurements were also recorded at 0, 30, and 60 minutes. Three
separate experiments were performed in triplicate with the results normalized in a percent
survival curve and recorded.
Br200 EC under visible light dropped to zero percent alive within 30 minutes for
all experiments and within 20 minutes for two of the three experiments. VLP7000 EC
and BrNMP EC dropped to 0% within 60 minutes for two of the three experiments.
Student T-Tests were performed with an alpha of 0.05. At zero minutes all
variables were not significantly different and results were normalized at 100%. At ten
minutes of exposure to visible light Br200 EC (51%) and BrNMP EC (59%) were
significantly different to EC alone (88%) with p values of 0.0014 and 0.0001,
respectively. VLP700 EC dropped to 79%. VLP7000 EC was significantly different to
Br200 EC (p=0.0275). Other variables were not significantly different at 10 minutes. At
20 minutes exposure, Br200 EC (13%) and BrNMP EC (54%) were significantly
different to EC alone (78%) with p values of 0.0016 and 0.0214, respectively. VLP7000
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EC (65%) was significantly different to Br200 EC (p=0.0105).

Br200 EC was

significantly different to BrNMP EC (p=0.0003). Other variables were not significantly
different at 20 minutes. At 30 minutes exposure to visible light, VLP7000 EC (54%),
Br200 EC (0%) and BrNMP EC (52%) were significantly different to EC alone (88%)
with p values of 0.0109, 3.9x10-6 and 0.0009, respectively. VLP7000 EC was
significantly different to Br200 EC (p=0.0001). Br200 EC was significantly different to
BrNMP EC (p=3.06x10-6). Other variables were not significantly different at 30 minutes.
At 40 minutes exposure to visible light, VLP7000 EC (38%), Br200 EC (0%) and
BrNMP EC (53%) were significantly different to EC alone (75%) with p values of
0.0001, 1.4x10-6 and 0.0296, respectively. VLP7000 EC was significantly different to
Br200 EC (p=0.0004). Br200 EC was significantly different to BrNMP EC (p=2.69x105

). Other variables were not significantly different at 40 minutes. At 50 minutes exposure

to visible light, VLP7000 EC (22%), Br200 EC (0%) and BrNMP EC (45%) were
significantly different to EC alone (80%) with p values of 0.0007, 1.92x10-8 and 0.0024,
respectively. VLP7000 EC was significantly different to Br200 EC (p=0.0365) and
BrNMP EC (p=0.0056). Br200 EC was significantly different to BrNMP EC (p=0.0003).
At 60 minutes exposure to visible light, VLP7000 EC (2.7%), Br200 EC (0%) and
BrNMP EC (10%) were significantly different to EC alone (65%) with p values of
4.36x10-5, 2.86x10-8 and 0.0006, respectively. Other variables with visible light exposure
were not significantly different at 60 minutes.
EC alone samples that remained in the dark throughout 30 (98%) or 60 minutes
(103%) were not significantly different from EC alone (100%) at zero minutes. VLP7000
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EC was significantly different at both 30 (77%) and 60 minutes (66%) when compared to
it zero time point (100%) with p values of 0.0237 and 0.0145 respectively. Br200 EC was
not significantly different to the zero time point (100%) from either the 30 (95%) or 60
minute (95%) time points. BrNMP EC was significantly different to the 30 (80%) and 60
minute (80%) time points with p values of 6.78x10-5 and 0.0056, respectively.
Comparing EC alone under visible light at 30 minutes (88%) to EC alone in the
dark 30 minutes (98%) was significantly different with a p value of 0.0333. EC alone at
60 minutes comparing visible light (65%) to dark (103%) exposure was also significantly
different (p=0.0042). VLP EC at 60 minutes comparing visible light (2.7%) to dark
(66%) exposure was significantly different (p=0.0013). Comparing Br200 EC under
visible light at 30 minutes (0%) to Br200 EC in the dark at 30 minutes (95%) was
significantly different with a p value of 9.996x10-9. Br200 EC at 60 minutes comparing
visible light (0%) to dark (95%) exposure was also significantly different (p=2.48x10-8).
Comparing BrNMP EC under visible light at 30 minutes (52%) to BrNMP EC in the dark
at 30 minutes (80%) was significantly different with a p value of 0.0002. BrNMP EC at
60 minutes comparing visible light (10%) to dark (80%) exposure was also significantly
different (p=0.0003). Br200 results indicated a much stronger killing capability than
either VLP7000 or BrNMP under visible light.
P or B sub-coatings with or without Br200, BrNMP, or P25 Titania (2mg/38mm2
surface) were evaluated every 10 minutes under UVA irradiation for 0-60 minutes.
Depicted in Figure 15, are the photocatalytic activity results with the P sub-coating.
Br200, P25, and BrNMP results yielded a 4 log drop in viable cells within 30, 40, or 50
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minutes, respectively. EC alone or on the P sub-coating exposed to UVA remained
viable. All samples exposed to the dark for 1 h remained viable. Student T-Test indicated
significant difference at an alpha of 0.05 between EC at 0 min to P25, not significantly
different at 0 or 10 min UVA; significantly different at 20 – 60 min VL (p= 2.5 x 10-5 –
1.3 x 10-6), and at 30 – 60 min D (p= 0.039 – 0.002); between EC at 0 min to Br200, not
significantly different at 0 or 10 min UVA or 30 – 60 min D (p= 0.3 – 0.2), but
significantly different at 20 – 60 min UVA (p= 5 x 10-4 – 1. X 10-6); and between EC at 0
min to BrNMP, not significantly different at 0 or 10 min UVA, or 30 – 60 min D, but
significantly different at 20 – 60 min UVA (p= 0.001 – 1.3 x 10-6).
Figure 16 shows the results of the UVA activation (365 nm, 363-364 µW/cm2) of
Br200, BrNMP, or P25 on the B sub-coating. Br200 killed the total EC with a 4 log drop
in 40 minutes. BrNMP or P25 completely reduced the viable count to 0 at 50 and 60
minutes, respectively. Binder under UVA irradiation and P25 in the dark reduced the cell
population by ~20%. EC alone and all variable dark exposed samples except P25 in the
dark maintained the viable population of cells. Student T-Test indicated significant
difference at an alpha of 0.05 between EC at 0 min to P25, not significantly different at 0
min UVA; significantly different at 10 – 60 min UVA (p= 0.01 – 0.001), and at 30 – 60
min D (p= 0.04– 0.002); between EC at 0 min to Br200, not significantly different at 0
min UVA or 30 – 60 min D (p= 0.3 – 0.2), but significantly different at 10 – 60 min
UVA (p= 0.001 – 0.01); and between EC at 0 min to BrNMP, not significantly different
at 0 min UVA or 60 min D, but significantly different at 10 – 60 min UVA (p= 0.04 –
0.001), or 30 min D (p= 0.01).
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P or B sub-coatings with or without Br200, BrNMP, or vlp7000 Titania
(2mg/38mm2 surface) were evaluated every 10 minutes under VL (Cool White 8 Watt
lamp, 0.1mW/cm2) for 0-60 minutes (Figures 17 and 18). Additionally, Br200 was tested
at 0, 1, 2, 4, 6, 8, and 10 minutes separately with the proper controls to determine the
survival curve. Depicted in Figure 17, are the photocatalytic activity results using the P
sub-coating. Br200, BrNMP, and vlp7000 results yielded a 4 log drop in viable cells
within 8, 30, or 40 minutes, respectively. EC alone or EC on the P sub-coating exposed to
VL irradiation remained viable. All samples exposed to the dark for 1 h remained viable.
Student T-Test indicated significant difference at an alpha of 0.05 between EC at 0 min to
P25, not significantly different at 0 min VL or 30 – 60 min D; significantly different at 10
– 60 min VL (p= 0.01 – 0.003); between EC at 0 min to Br200, not significantly
different at 0, 2, 4, or 6 min VL or 30 – 60 min D (p= 0.3 – 0.2), but significantly
different at 8 – 60 min VL (p= 0.002 – 4 x 0-11); and between EC at 0 min to BrNMP, not
significantly different at 0 min VL or 30 – 60 min D, but significantly different at 10 – 60
min VL (p= 0.02 – 0.002).
Figure 18 shows the results of the VL activation of Br200, BrNMP, or vlp7000 on
the B sub-coating. Br200 killed the total EC with a 4 log drop in 40 minutes. BrNMP or
vlp7000 completely reduced the viable count to 0 at 50 or 60 minutes, respectively.
Binder under VL irradiation reduced the cell population by ~20%. EC alone exposed to
VL and all variable samples in the dark maintained the viable population of cells. Student
T-Test indicated significant difference at an alpha of 0.05 between EC at 0 min to
vlp7000, not significantly different at 0 or 10 min VL or 30 – 60 min D; significantly
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different at 20 – 60 min VL (p= 0.005 – 0.001); between EC at 0 min to Br200, not
significantly different at 0, 2, 4, or 6, min VL or 30 – 60 min D (p= 0.3 – 0.2), but
significantly different at 8 – 60 min VL (p= 0.01 – 0.0002); and between EC at 0 min to
BrNMP, not significantly different at 0 min VL or 30 – 60 min D, but significantly
different at 10 – 60 min VL (p= 0.04 – 0.0002).

3.4 Discussion
X-ray Photoelectron Spectroscopy (XPS) verified that Titanium molecules were
present on the surface of the coatings, allowing the Titania to have direct contact with the
organic substance to be oxidatively degraded. TiO2 P-25 was free of Cl 2p while Brookite
contained 2.31% mass concentration. This may have contributed to the increased
oxidative efficacy of the Brookite. Both contained small amounts C 1s which may have
come from atmospheric pressure rather than as a consequence of the precursor [62].
X-ray Diffraction (XRD) confirmed the peaks of Br200 and BrNMP to the
original powder sample peaks [66, 68]. This verified that the Br200 and BrNMP Titania
coatings should have the same percent of TiO2 phases meaning the specific type of
crystal lattice structure contained within each sample as the nanoparticle powders with
approximately 44-45% Anatase, 53% Brookite, and 2-3% Rutile.
Low temperature calcination of 200oC for 2 h on both Br200 and BrNMP Titania
produced crystallite sizes ranging from 5-8 nm, therefore, providing a very high surface
area ranging from (BET) 138 - 157 m2/g [65]. This provides a significantly greater
surface area per particle than the Degussa commercial P25 reference standard at (BET)
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56 m2/g with 79% Anatase and 21% Rutile phase TiO2. The Kronos vlp7000 has an
approximate 15 nm crystallite size with a surface area of (BET) 225 m2/g and a stable
working pH range of 4 – 9. The Kronos vlp7000 has a much larger surface area than the
Brookite samples. The crystal lattice structure of Br200 and BrNMP contains Brookite
phase which is orthorhombic and Anatase phase which is tetragonal. Kaewgun and
colleagues proposed that the mixture of orthorhombic phase and tetragonal phase in
Br200 or BrNMP caused a slower electron/hole recombination due to the transfer
between the two phases of crystallites [69]. Even though the Kronos vlp7000 has a much
larger surface area of (BET) 225 m2/g than the polymorphic Brookite (BET) 157 m2/g
[66], it is made with pure Anatase and the single phase product may contribute to a faster
electron/hole recombination, decreasing the photocatalytic efficiency.
The two different sub-coatings displayed different hydrophilic properties. The P
sub-coating exhibited extreme hydrophilic surfaces as shown in Figure 4, while the B
sub-coatings exhibited hydrophobic surfaces. The P coatings contained strong
polyelectrolytes and were rinsed in neutral pH nanopure 18Ω water between each layer
and after completion. In contrast, the B sub-coating is finalized at pH3. The surface tack
and surface gloss were both observed to be low in the P sub-coating and both were
observed to be high in the B sub-coating. After the liquid phase deposition of the Titania
followed by air drying, the surface gloss of the P sub-coating remained lower than the
surface gloss of the B sub-coating. Bacteria are attracted to the hydrophilic surface of the
P sub-coatings with Titania. Therefore the bacteria can interact more quickly with the
Titania and its free radicals causing oxidative death more quickly. The hydrophobicity of
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the B sub-coating can repel the negative charge of the bacteria. This could be the factor
that causes the P sub-coating to provide faster killing. The distance and orientation of the
bacteria to the active sites of the Titania are also factors affecting the photocatalytic
activity.
Other considerations that may increase the enhancement effect of the P subcoating over the B sub-coating include the following. According to mindat.org, it was
named for Henry James Brooke (1771-1857), who was an English crystallographer and
mineralogist. The length of edges on the orthorhombic crystallite of Brookite phase
Titania are, a=5.4558 Å, b=9.1819 Å, and c= 5.1429 Å, where 1 nm = 10 Å [70]. The
OHBA crystal structure site labeled the Brookite Space group as Pbca and the Pearson
symbol as oP24 [71]. OHBA reported that it contains approximately two atoms thick
with four layers on one edge, boding well for surface adsorption of N and S. Because the
crystallite particle sizes are 5-8 nm in diameter, bulk properties break down, surface area
and surface tension to volume significantly increases causing surface effects to dictate
properties [71].

Light absorption and re-emission properties change. Due to ionic

bonding, the ion size of the Sulfur in either the +4 state (0.37 Å), or the +6 state (0.29 Å)
or ion size of the Nitrogen in either the +3 state (0.16 Å) or the +5 state (0.13 Å),
indicates that either one could easily adsorb to the surface [72]. This would aid in
broadening the absorption edge, narrowing the band-gap, causing the photocatalytic
activity of Br200 and BrNMP to significantly increase.
Buffer composition and pH play a strong role in the oxidative ability of TiO2 to
kill bacteria. The PBS contained phosphate anions which strongly adsorb to TiO2 forming
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bidentate complexes, shifting the isoelectric point down towards pH 2.0 [62, 73-74].
This may have caused a lack of adjacent sites to the oxide, hence, preventing the
formation of tetrahedrally coordinated water. pH values below the isoelectric point of the
TiO2 may possibly flip the water dipoles [62]. The TiO2 in water at pH 4.0 proved to
have more efficient results in killing the bacteria than pH 7.4 whether in water or PBS.
These results indicate that photocatalytically activated TiO2 P-25 or Brookite at pH 4.0,
optimum pH and diluent, can provide a non-selective modality for decreasing the
transmission of pathogenic bacteria
MO oxidative degradation occurred in significantly less time with the Br200 and
BrNMP Titania on either the P or B sub-coatings than the commercial P25 or vlp7000
Titania. Both the Br200 and BrNMP Titania on the P sub-coating was significantly faster
than the B sub-coating to complete the MO degradation by 2 – 4 h under both UVA and
VL irradiation. Neither P nor B sub-coating alone significantly degraded MO over the 26
h time period.
Using the BacLight™ Assay, UVA irradiation on suspended Br200 Titania was
90 minutes faster than BrNMP, or P25 Titania in AW. While in the lower cell population,
enumerating with viable cell counts, the commercial P25 was faster by 30 seconds at
completing the 4 log kill of cells than Br200. That was the first time in this study that the
commercial P25 was faster than Br200.
Evaluating the effects of VL irradiation to photocatalytically activate the
suspended Br200, BrNMP or vlp7000 Titania on bacterial killing resulted in Br200
displaying a complete elimination of viable bacteria within 30 minutes. P25 Titania
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required twice the amount of time and BrNMP did not complete the elimination in the 60
minute time period.
Br200 Titania on either P or B sub-coating, with either UVA or VL irradiation
eliminated all viable cells from 10 – 22 minutes faster than the next fastest Titania type.
With either UVA or VL irradiation, Br200, BrNMP, and P25 (UVA) or vlp7000 (VL) on
the P sub-coating averaged total elimination of viable cells 10 minutes faster than with
the Titania on the B sub-coating. VL irradiation (0.1mW/cm2) activated all appropriate
types of Titania equally or better than UVA irradiation at 363-364 µW/cm2 on
appropriate Titania samples.

3.5 Conclusions
Light intensity, wavelength, surface material characteristics, pH, band gap,
efficiency of hole-electron recombination, amount of dissolved oxygen, broad edge
(indirect bandgap) versus sharp edge (direct bandgap), number of available active surface
sites, and bacterial load affect efficiency of photo-oxidation. Based on the results
obtained in this study, Br200 Titania on the P Sub-Coating provided superior oxidative
activity on both MO degradation and EC bacterial killing. One explanation is reported by
Zallen and Moret, 2006. At ambient temperature, natural Brookite TiO2 crystals were
examined via optical-absorption ranging from 2.1 to 3.54 eV.

The Brookite TiO2

absorption edge is broad, continuing throughout the visible range with no direct gap [9].
In contrast to tetragonal forms, the orthorhombic structure encompasses a larger range of
bond lengths from the six unique nearest-neighbor Ti-O bond lengths. They suggest that
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Brookite TiO2 is an indirect-gap semiconductor with a bandgap approximating 1.9 eV
[9].
The low temperature method in which the Br200 or BrNMP were formed and
calcined, produced small crystallite sizes ranging from 5 – 8 nm in diameter, and a large
surface area, approximately (BET) 157 m2/g [66]. The monolith bulk properties give
way to surface effect characteristics as the crystallites are four layers on one edge and
two atoms thick enabling N and S surface adsorption [70-72]. This large surface area
would provide more opportunities for contact with molecules. The smaller crystallite
sizes allow for more particles to make up a specific mass, hence providing more surface
area due to higher numbers of particles. vlp7000 contains a larger surface area to volume
ratio of (BET) 225 m2/g than Brookite. Therefore, the higher activities of the Br200 or
BrNMP may be from the polymorphic composition in the combination of Brookite and
Anatase. This combination may cause the electron/holes to recombine more slowly since
the electrons must travel from one type of lattice structure to a different type of lattice
structure, while vlp7000, made of pure Anatase, produced efficient electron/hole
recombination. Thus, the Br200 and BrNMP in conjunction with the P sub-coating were
superior to vlp7000 in visible light.
Based on our results, Br200 on P Sub-Coating consistently had stronger
photocatalytic activity than BrNMP on P or B Sub-Coating. Theory suggested it should
have been the opposite since BrNMP is associated with a Nitrogen containing compound,
N-methylpyrrolidone at 168oCelsius for 4 h (4g/200mL) as described in [65]. Charred
organic residue of NMP remaining on the surface covered up or was bound to active sites
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on the Brookite, providing less photocatalytically active sites to oxidize bacteria. It was
found that temperatures of 420oC were required to remove all of the extraneous NMP,
and these high temperatures caused phase changes to a more Anatase product and
sintering which caused reduction in surface area to volume ratio, decreasing the
photocatalytic activity [68]. Since bacteria are much larger than the Titania crystal
particles whether in suspension or bound onto a surface, distance and orientation effects
would be more pronounced for bacteria than for Methyl orange [61].
Also one may propose that the hydrophobic nature of the B Sub-coating may have
delayed the BrNMP activity, but all samples were exposed to the B Sub-coating and
Br200 was more active than BrNMP, again due to residual charred organic residue and
blockage of potential photocatalytic active sites. However, each Titania on the P coating
performed complete biocidal killing 10 minutes faster than its counterpart on the B Subcoating.

This may be the difference in the effect of the P Sub-coating super-

hydrophilicity attracting the bacteria versus the B Sub-coating

hydrophobic

characteristics repelling the bacteria. The P sub-coating containing N and S molecules in
different ionic states, through surface interaction affect the Titania. These effects
lengthened the absorption edge into the visible range, narrowed the band-gap, thereby
increasing the photocatalytic activity of the Titania.
Br200 results indicate that it has a stable pH working range that includes pH 3-4.
The B sub-coating has a pH of 3 and the AW that was used in the experiments was at pH
of ~4. The super hydrophilic surface characteristics of the P sub-coating aid in attracting
the bacteria to adhere while hydrophobic coatings may even repel the bacteria somewhat.
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EC and many other species of bacteria contain hydrophilic fimbriae that attach to biotic
and abiotic surfaces [31-32].
After the bacteria adhere to the surface of the photocatalytically activated Br200
Titania surface, bacterial death ensues via two main mechanisms. First, consecutive
oxidative attacks to the cell wall / membrane via the hydroxyl radical (HO-)

[75]

destabilize the cell wall. Secondly, the oxygen located on the TiO2 surface can act in its
molecular form as an electron acceptor in the superoxide anion radical form. When the
adhered bacteria have direct contact with the photo-generated holes, their cell walls /
membranes are further destabilized and decomposition ensues via irreversible loss of
electrons and direct bond disruption at the TiO2 surface [75-77]. After the cell wall is
disrupted, the presence of superoxide anions and hydrogen peroxide, the Fenton and
Haber-Weiss Reactions continue to produce hydroxyl radicals inside the bacteria,
oxidizing the DNA. Chen and colleagues observed a correlation between the
decomposition of bacteria and organics such as MO [78]. Therefore, based on this
research, P sub-coatings with Br200 Titania displays a superior non-selective method of
killing bacteria. This novel P Sub-Coating with bound Br200 Titania could provide nonselective surface coatings in the hospital, surgical, and long term care arenas to aid in
prevention of transmission of pathogens and prevention of biofilm formation. In fact,
because this coating is turned “on” when light is on (10-9 seconds) [59], and turned “off”
when light is off, it could be used in many nosocomial settings, community settings, and
on appliances, cars, and a vast number of other surfaces.
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This work provided new evidence of low temperature association between the P
sub-coating molecules and surface characteristic effects of the Titania showing superior
photocatalytic activity on MO degradation and bactericidal properties.

3.6 Experimental
Titanium dioxide Br200 and BrNMP nanoparticles samples were generously
given to our lab by Dr. B. I. Lee and Dr. S. Kaewgun of Clemson University. Br200
nanoparticles were made by the WACS process as described in [66]. This sample was
calcined at 200oCelsius for 2 hours (h) in air. SACS-NMP (BrNMP) was made by the
WACS process with a SACS post treatment carried out in N-methylpyrrolidone at
168oCelsius for 4 h (4g/200mL) as described in [65]. This BrNMP sample was calcined
in air at 200oCelsius for 2 h. For the long wave ultraviolet light (UVA) (365nm)
comparisons, the commercial TiO2, P25 from Degussa, (Evonik Industries AG, Germany)
was used. For the Visible Light comparisons, the commercial Kronos vlp7000
(KRONOS, Inc., Dallas, TX) was used.
A super hydrophilic layer-by-layer (LBL) polyelectrolyte sub-coating using 0.1M
Poly (diallyldimethylammonium chloride) (PDDA) and 0.1M Poly(styrenesulfonic acid)
in nanopure water, separately, modifying the method from Tsuge et al. 2008 [79]. PDDA,
Mw ~200,000–350,000, 20 wt.% aqueous solution), and PSS, Mw ~75,000, 18 wt.%
aqueous solution) were purchased from Sigma-Aldrich. Due to the strong polyelectrolytic
nature of PDDA and PSS, the pH was not adjusted.
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At ambient room temperature #2 micro-cover-glass slips (22 mm diameter)
(Electron Microscopy Sciences, Hatfield, PA) were prepared to receive the
polyelectrolytes via Tsuge et al. 2008 method [79]. The 25-LBL coatings were made
beginning with PDDA and ending with PSS and air dried. In this publication, the
PDDA/PSS sub-coated slides will be labeled P. Another binder graciously provided by
Dr. B.I. Lee was used, GPTS:TEOS (5:3) with HNO3 and EtOH at pH = 3 to compare
and test the effectiveness of the two sub-coatings. Aliquots (50 µL) of the binder (B) was
deposited onto the glass cover slips and air dried. The glass cover slips sub-coated with
either P or B were placed on a clean baking sheet.
Five mol of 3-glycidoxypropyl-trimethoxysilane (Gelest) was mixed with 3 mol
of Tetramethyl orthosilicate (Alfa Aesar). Ethanol prehydrolyzed the solution (Alfa
Aesar) at room temperature with constant stirring for 3h. Nitric acid was added to bring
the pH to 3. Two aliquots of 50 µL of Binder were aseptically pipetted onto sterile glass
cover slips with drying at room temperature in between. Then the coated slides were
aseptically stored in a 24 well plate for further use.
Each Titania, Br200, Br-NMP, P25, or vlp7000 was mixed into nanopure water
containing 2mL of 0.1M HCl per 100mL of water pH ~4. The acidic water is referred to
as AW. The final Titania concentration was 6.67mg Titania/mL water. The liquid Titania
suspensions were sonicated (Sonicator FS30H; Fisher Scientific) for 1 h and vortexed.
Each sub-coated cover slip received 2 aliquots of 150 µL of Br200, Br-NMP, P25, or
vlp7000 suspension, (2mg/38mm2) with ambient air drying between aliquots. The Titania
cover-slips were heated in a toaster oven at 60oC for 1 h prior to use.
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X-ray Photoelectron Spectroscopy (XPS) (Axis 165, Kratos; 20mA, Anode HT
(12kV) was performed on the P sub-coating with and without Titania (pass energy of 40
with 0.5eV step, 120ms-dwell time and 3 sweeps per sample). Both general and highresolution scans were performed. The XPS evaluation will identify elements on the
surface of the sample. An X-ray powder diffractometer was used to determine phase
composition and crystallite size of the TiO2 samples using a Rigaku ULTIMA IV with
CuKα radiation at 1.5418Å, continuous scans with a sampling width of 0.020° over a
range of 20 to 350 (2θ). Hydrophilicity was determined by dropping 10 µL of nanopure
water onto the surface of the coating. A close up picture was taken from the direct side
view for evaluation of the hydrophilic properties of each surface.
Contact angle of a surface will identify the wet-ability of a surface as shown in
Figure 2. A hydrophilic surface is more difficult for hydrophobic walled bacteria to
attach, therefore, decreasing bacterial attachment and biofilm formation. Using a macrodigital camera, we will determine the hydrophobic/hydrophilic characteristics of each
sample’s surface via contact angle measurement. Each coating type will receive a 10 µL
drop of 18 Ω nanopure water.
Assuming a spherical or ellipsoid liquid droplet surrounded by gas resting on a
solid surface, we will measure the hydrophilicity of the surface on our samples (n=4).
Using a high resolution micro-lens camera, pictures will be taken of the three phase
boundary where the liquid, gas, and solid intersect. The contact angle, θC, is the angle
formed by a liquid at this three phase boundary and can be expressed by Young’s
Relation depicted in Figure 11 and Equation 1 below.
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(1)

Where:

= Interfacial tension between the solid and gas
= Interfacial tension between the solid and liquid
= Interfacial tension between the liquid and gas

The B or P sub-coatings with or without Br200, Br-NMP, P25, or VLP7000
Titania were evaluated for photocatalytic activity. An empty well with Methyl Orange
(MO) was used for the control. A multiple ray lamp (MRL, Model 58; Fisher Scientific)
with different 8 Watt tubes UVA (365nm) at 363-364 µW/cm2) and visible light (Cool
White) at 0.100 mW/cm2) was utilized as the source for photoactivation. The intensity of
light was verified with a UVX Digital Radiometer, (Model-UVX, UVP, Inc., Upland,
CA) and an ACCU- CAL-50-V (Dymax Corporation, CT) for UVA and visible light,
respectively. Polystyrene plates (24-well) containing the Titania coated cover slips were
secured onto a microplate orbital mixer (Microplate Genie, Model SI-0400, VWR). One
milliliter of 20 µM MO solution was added to each well. A non-fluorescing optically
clear film (TemPlate® RT Optical Film, 2978-2700, USA Scientific, Inc.) was adhered to
the polystyrene plate to prevent evaporation of the MO. The lamp intensity was adjusted
to accommodate the film.
Uniform samples were removed at 2 h intervals (0-26 h). Each sample containing
Titania was filtered through a Puradisc™ 25 AS Disposable Filter Device with a 0.2 µm
Polyethersulfone Membrane (Whatman, USA) to remove any possible free Titania, and
to prevent false positive absorbance via scattering. Quantitative spectral results were
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obtained with a Genesys 20 Thermo Spectronic spectrophotometer at 490 nm (Model
4001/4, Thermo Scientific, USA). The percent of MO oxidative degradation, D, was
plotted against time in hours shown in Equation 2, where A0 is the initial peak intensity at
490 nm, and A is the instantaneous peak intensity at 490 nm.

(2)
Escherichia coli B (E. coli B) (ATCC 11303, Manassas, VA) was purchased from
the American Tissue Culture Collection (ATCC). Cultures incubated in Tryptic Soy
Broth (TSB) for 12-14 h in an Environmental Incubator Shaker (Model G24, New
Brunswick Scientific) were harvested and centrifuged at 7,000 x g in a microcentrifuge
(Eppendorf Centrifuge, Model 5417R). Stock cultures of E. coli B were frozen in TSP +
5% Glycerol and stored at -80oC till further use.
Because Phosphate has a very high affinity to TiO2, acidic sterile water (AW) at
~pH4 (2mL of 0.1M HCl / 100mL water) was used for these assays instead of Phosphate
Buffered Saline. Cells were washed three times in AW with centrifugation. Upon resuspension, the cells were standardized at an Optical Density (OD) of 600 n using a
BioRad Smart Spec 3000 (BioRad, USA). A result of 0.2 at OD600 is roughly equivalent
109 CFU/mL of E. coli B as calculated from replicate dilution curves. All experiments
were performed three times in > triplicate each.
E. coli B (ATCC 11303, Manassas, VA) were maintained in Tryptic Soy Broth
medium for 12-16h at 37oC and examined in a direct contact model using the Free
Suspension Assay [67] for 0-2h with or without TiO2 (1mg/mL) P-25 or Brookite-200,
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separately. TiO2 nanoparticles were activated under long range ultra violet (UV) light
(365nm; 364µW/cm2) at time points of 0, 30, 75, and 120 minutes in sterile water at pH 4
or pH 7.4, or in Phosphate buffered saline (PBS) at pH 7.4. Quantification of bacterial
culture by Optical Density (OD) 600nm was verified prior to each experiment.
Quantification of E. coli B was performed in triplicate by dilution plating with a Spiral
Plater (Spiral Biotech, Norwood, MA) on Tryptic Soy Agar and incubated 24 h at 37oC
and counted.
To reduce the amount of material, time, labor, and cost, two different assay types
were evaluated in order to miniaturize the assays. Dilution curves of E. coli B (n=8) were
evaluated. The Live/Dead® BacLight™ Bacterial Viability Assay (L-7012, Molecular
Probes, Eugene, OR) is a fluorescence based assay for distinguishing live and dead
bacteria in a mixed population. SYTO® 9 green-fluorescent nucleic acid stain (480/500
nm) penetrates healthy bacterial cells labeling all bacteria in a population; propidium
iodide (490/635 nm) penetrates only bacteria with damaged membranes, causing a
reduction in the SYTO 9 stain fluorescence when both dyes are present.
A second assay was also evaluated. The Luminescent Assay Bac Titer-Glo™
Microbial Cell Viability Assay (Promega: Madison, WI, USA) quantitates the amount of
ATP present in metabolically active cells. It is based on the luciferase reaction. Monooxygenation of luciferin is catalyzed by luciferase in the presence of Mg2+, ATP, and
molecular oxygen.
Because Phosphate has a very high affinity to TiO2, acidic sterile water (AW) at
~pH4 (2mL of 0.1M HCl / 100mL water) was used for these assays instead of Phosphate
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Buffered Saline. Cells were washed three times in AW with centrifugation. Upon resuspension, the cells were standardized at an Optical Density (OD) of 600 n using a
BioRad Smart Spec 3000 (BioRad, USA). A result of 0.2 at OD600 is roughly equivalent
109 CFU/mL of E. coli B as calculated from replicate dilution curves.
The six well – six mL volume free suspension assay was miniaturized to a 24 well
format using a 1 mL volume assay. Many testing variables could evaluated at the same
time under this new assay format. A non-fluorescing optically clear film (TemPlate® RT
Optical Film, 2978-2700, USA Scientific, Inc.) was adhered to the polystyrene plate to
prevent evaporation of the bacterial suspension in AW. The lamp intensity was adjusted
to accommodate the film via the Radiometers.
After testing, 100 µL aliquots (n=4) from each sample well was dispensed into a
96 well black or white plate for fluorescence or luminescence assay, respectively. The 24
well testing assay in combination with either the fluorescent LIVE/DEAD® BacLight™
Bacterial Viability Kit or the luminescent BacTiter-Glo™ Microbial Cell Viability Assay
was evaluated after subtracting the background and to determine if the background was
too large. Different Titania concentrations were evaluated, 0.1 mg/mL, 1 mg/mL or 10
mg/mL in both assays.
Miniaturized, modified free suspension assays were performed to determine a
starting point for the amount of TiO2 to use in the coatings. Because preliminary dilution
curve results indicated linearity with minimal background in the 103 to 108 CFU/mL or
102-107 CFU/mL range with the LIVE/DEAD® BacLight™ Bacterial Viability Kit or the
luminescent BacTiter-Glo™ Microbial Cell Viability Assay, respectively, these assays
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were used for higher bacterial loads in experiments, specifically the BacLight™ as it
conserved time better than the cTiter-Glo™ with similar results. All modified free
suspension assay Titania concentrations were 1 mg/mL.
To determine the lower viable range (100-104 CFU/mL) of E. coli B, either Spiral
Plating (Spiral Biotech Autoplate, Model 4000) or manual cell spreading on Tryptic Soy
Agar petri dishes were performed in triplicate. The bacteria were incubated at 37oC for
~24 h and enumerated. Results from these assays are normalized and plotted as Time (xaxis) versus % Survival (y- axis). Calculations were based on the number of viable cell
counts at various time points as percentages described in Equation 3. All experiments
were replicated for reproducibility.
_ Number of Viable Cells (CFU/mL) at Time t_____ X 100

(3)

Number of Viable Cells (CFU/mL) at Time t0
E. coli B cultures were incubated in TSB for 12-14 h in an Environmental
Incubator Shaker (Model G24, New Brunswick Scientific). The cultures were harvested
and centrifuged at 7,000 x g in a microcentrifuge (Eppendorf Centrifuge, Model 5417R)
in AW. The coated cover slips (22 mm in diameter) (#72227-01, No2 Micro Coverglass;
Electron Microscopy Sciences, Hatfield, PA) were aseptically inserted into 24 well
plates. Because the 24 well plates used had a 22.2 mm diameter bottom, a secure ring was
not needed to retain the bacteria on the coated cover slip.
Because Phosphate has a very high affinity to TiO2, acidic sterile water (AW) at
~pH4 (2mL of 0.1M HCl / 100mL water) was used for these assays instead of Phosphate
Buffered Saline. Cells were washed three times in AW with centrifugation. Upon re-
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suspension, the cells were standardized at an Optical Density (OD) of 600 n using a
BioRad Smart Spec 3000 (BioRad, USA). A result of 0.2 at OD600 is roughly equivalent
109 CFU/mL of E. coli B as calculated from replicate dilution curves.
E. coli B cells at 1 x 104 CFU/mL AW were aliquoted 1 mL per well into a 24
well plate containing various coated cover slips. Exposure times of 0, 2, 4, 6, 8, 10, 20,
30, 40, 50, or 60 minutes were evaluated. At the end of each time period, the samples of
E. coli B (50 µL), using either Spiral Plating (Spiral Biotech Autoplate, Model 4000) or
manual cell spreading on Tryptic Soy Agar petri dishes were performed in triplicate. The
bacteria were incubated at 37oC for ~24 h and enumerated. Results from these assays are
normalized and plotted as Time (x- axis) versus log 10 Survival (y- axis). Calculations
were based on the number of viable cell counts at various time points as percentages
described in Equation 3.
The B or P sub-coatings with or without Br200, Br-NMP, P25, or VLP7000
Titania were evaluated for photocatalytic activity. Sub-coatings alone without Titania
were used for the controls. A multiple ray lamp (MRL, Model 58; Fisher Scientific) with
different 8 Watt tubes UVA (365nm) at 363-364 µW/cm2) and visible light (Cool White)
at 0.100 mW/cm2) was utilized as the source for photoactivation. The intensity of light
was verified with a UVX Digital Radiometer, (Model-UVX, UVP, Inc., Upland, CA) and
an ACCU- CAL-50-V (Dymax Corporation, CT) for UVA and visible light, respectively.
Polystyrene plates (24-well) containing the Titania coated cover slips were secured onto a
microplate orbital mixer (Microplate Genie, Model SI-0400, VWR). One milliliter of 1 x
104 E. coli B in AW was added to each well. A non-fluorescing optically clear film
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(TemPlate® RT Optical Film, 2978-2700, USA Scientific, Inc.) was adhered to the
polystyrene plate to prevent evaporation of the bacterial suspension in AW. The lamp
intensity was adjusted to accommodate the film via the Radiometers.
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3.8 Figures

A
Figures 3.8.1. A-E - Surface chemical spectra of sub-coating with and without
Titania
Figure 3.8.1. A aXPS spectra graph of PSS/PDDA sub-coating
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B
Figure 3.8.1. B bXPS spectra graph of PSS/PDDA sub-coating with commercial P25
Titania
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C
Figure 3.8.1 C cXPS spectra graph of PSS/PDDA sub-coating with Br200 Titania
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D
Figure 3.8.1 D cXPS spectra graph of PSS/PDDA sub-coating with BrNMP Titania
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E
Figure 3.8.1 E cXPS spectra graph of PSS sub-coating with vlp7000 Titania
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Figure 3.8.2. X-ray diffraction spectra of the PDDA/PSS sub-coating with or without

Titania
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Figure 3.8.3. X-ray diffraction spectra of the Binder sub-coating with or without Titania
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Figure 3.8.4. Hydrophilicity of PDDA/PSS and Binder sub-coating with and without
Titania
A) PDDA/PSS
B) PDDA/PSS with P25
C) PDDA/PSS with VLP7000
D) PDDA/PSS with Br200
E) PDDA/PSS with BrNMP
F) Binder
G) Binder with P25
H) Binder with VLP7000
I) Binder with Br200
J) Binder with BrNMP

89

100

% Methyl Orange Degradation

80

60

40

20

0
0

4

8

12

16

20

24

28

Hours
MO

MO B

MO P

MO B P25

MO B Br200

MO P Br200

MO B BrNMP

MO P BrNMP

MO P P25

Figure 3.8.5. Photocatalytic Activities of Titania Coatings Under UVA
Statistics were determined using a student T-Test with alpha equal to 0.05. P or B Sub-Coating with MO
(20 µM) in water at pH 4.0 exposed to UV light (365nm) with a (363-364 µW/cm2) intensity in with or
without P- P-25 26+ h and P-Br200 14 h, or P-BrNMP 10 h, B- P-25 28+ h and B-Br200 22 h, or BBrNMP 18 h oxidative degradation of MO. Br200 and BrNMP were significantly different from 2 h -26 h
(p= 0.02 – 0.005); P25 was significantly different from16 h-28 h (0.044 – 0.032). MO alone or on P or BSub-Coating was not significantly different throughout the 26 h evaluated (p=0.35).
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Figure 3.8.6. Photocatalytic Activities of Titania Coatings Under Visible Light
Statistics were determined using a student T-Test with alpha equal to 0.05. P or B Sub-Coating with MO
(20 µM) in water at pH 4.0 exposed to VL with a (100 µW/cm2) intensity in with or without P- P-25 26+ h
and P-Br200 14 h, or P-BrNMP 14h, B- P-25 28+ h and B-Br200 16 h, or B-BrNMP 20 h oxidative
degradation of MO. Br200 and BrNMP were significantly different from 2 h -26 h (p= 0.03 – 0.004); P25
was significantly different from 8 h-28 h (0.03 – 0.01). MO alone or on P or B- Sub-Coating was not
significantly different throughout the 26 h evaluated (p=0.35).
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Figure 3.8.7. Activated TiO2 exposed to Escherichia coli B at pH 7.4 in water or PBS
for 120 Minutes
Results were determined using a student T-Test with alpha equal to 0.05. E. coli B in PBS pH 7.4 or water
at pH 7.4 exposed to UV light (365nm) in the absence or presence of TiO2 P25 or TiO2 Brookite
maintained the original bacterial population in 120 minutes. The pH of the water at 120 minutes dropped
from pH 7.4 to pH 6.0. (Error bars are too small to be seen.)
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Figure 7 - BacLight™ Fluorescent Assay Linearity Range on Escherichia coli B
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Figure 3.8.8. TiO2 Degradation of Escherichia coli B with or without UV at 0, 30, 75, or
120 Minutes in Water at pH 4.0
Results were determined using a student T-Test with alpha equal to 0.05. E. coli B in water at pH 4.0
exposed to UV light (365nm) in the presence of TiO2 P-25 and TiO2 Brookite had a significant seven log
drop in 120 (p=0.004) or 30 (p=0.001) minutes, respectively. E. coli B in the absence of TiO2 in water at
pH 4.0 depicted no significant reduction of the bacterial population in 120 minutes. The water beginning at
pH 4.0 remained the same throughout 120 minutes. (Error bars may be too small to be seen.)
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Figure 3.8.9. Static Contact Angle
http://en.wikipedia.org/wiki/Goniometer

Where:

= Interfacial tension between the solid and gas
= Interfacial tension between the solid and liquid
= Interfacial tension between the liquid and gas
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Figure 3.8.10. BacLight Fluorescent Assay Linearity Range on Escherichia coli B with p
values less than 0.05
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Figure 3.8.11. Bac-Titer-Glo™ Luminescent Assay Linearity Range on Escherichia coli
B with p values less than 0.05
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Figure 3.8.12. Effects of UVA Activated P25, Br200 and BrNMP Titania 1 mg/mL in
Free Suspension on E. coli B: BacLight ™Assay with p values less than 0.01
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Figure 3.8.13. Effects of UVA Activated P25 and Br200 Titania 1 mg/mL in Free
Suspension on E. coli B
Percent survival of E. coli B (EC) CFU/mL with and without P25 or Br200 Titania exposed to a UVA at
365 nm for either 0, 30, 60, 90, or 120 seconds or the dark for 0, 90, or 120 seconds. Student T-Test
indicated significant difference at an alpha of 0.05 between EC at 0 sec to P25, not significantly different at
0, or 90-120 sec in the dark, but significantly different at 30 – 120 sec in UVA (p= 0.004 – 0.002); between
EC at 0 min sec to Br200, not significantly different at 0 min UVA or 90 - 120 sec D or at 30 sec in UVA;
but significantly different at 60 – 120 sec in UVA (p= 0.006 – 0.002).
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Figure 3.8.14. Effects of Visible Light Activated VLP7000, Br200 and BrNMP Titania
1mg/mL in Free Suspension on E. coli B
Percent survival of E. coli B (EC) CFU/mL with and without VLP 7000, Br200, and BrNMP Titania
exposed to a cool white 8 Watt bulb for either 0, 10, 20, 30, 40, 50, or 60 minutes or the dark for 0, 30, or
60 minutes. Student T-Test indicated significant difference at an alpha of 0.05 between EC at 0 min to P25,
not significantly different at 0 or 10 min VL; significantly different at 20 – 60 min VL (p= 0.01 – 2.5 x 105
), and at 30 – 60 min D (p= 0.039 – 0.002); between EC at 0 min to Br200, not significantly different at 0
min VL or 30 – 60 min D (p= 0.3 – 0.2), but significantly different at 10 – 60 min VL (p= 0.001 – 1.9 x 08
); and between EC at 0 min to BrNMP, not significantly different at 0 min VL, but significantly different
at 10 – 60 min VL (p= 0.02 – 8.3 x 10-7), or 30 – 60 min D (p= 0.007 – 0.0005).
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Figure 3.8.15. Effects of UVA Light Activated P-25, Br200 and BrNMP Titania (2mg)
on the PDDA/PSS Sub-coating on E. coli B for 0-60 Minutes
Percent survival of E. coli B (EC) CFU/mL with and without P25, Br200, and BrNMP Titania on P SubCoating exposed to a UVA 365 nm lamp for either 0, 10, 20, 30, 40, 50, or 60 minutes or the dark for 0, 30,
or 60 minutes. (Error bars may be too small to see.) Student T-Test indicated significant difference at an
alpha of 0.05 between EC at 0 min to P25, not significantly different at 0 or 10 min UVA; significantly
different at 20 – 60 min VL (p= 2.5 x 10-5 – 1.3 x 10-6), and at 30 – 60 min D (p= 0.039 – 0.002); between
EC at 0 min to Br200, not significantly different at 0 or 10 min UVA or 30 – 60 min D (p= 0.3 – 0.2), but
significantly different at 20 – 60 min UVA (p= 5 x 10-4 – 1. X 10-6); and between EC at 0 min to BrNMP,
not significantly different at 0 or 10 min UVA, or 30 – 60 min D, but significantly different at 20 – 60 min
UVA (p= 0.001 – 1.3 x 10-6).
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Figure 3.8.16. Effects of UVA Light Activated P-25, Br200 and BrNMP Titania (2mg)
on the Binder Sub-coating on E. coli B for 0-60 Minutes
Percent survival of E. coli B (EC) CFU/mL with and without P25, Br200, and BrNMP Titania on B SubCoating exposed to a UVA 365 nm lamp for either 0, 10, 20, 30, 40, 50, or 60 minutes or the dark for 0, 30,
or 60 minutes. (Error bars may be too small to see.) Student T-Test indicated significant difference at an
alpha of 0.05 between EC at 0 min to P25, not significantly different at 0 min UVA; significantly different
at 10 – 60 min UVA (p= 0.01 – 0.001), and at 30 – 60 min D (p= 0.04– 0.002); between EC at 0 min to
Br200, not significantly different at 0 min UVA or 30 – 60 min D (p= 0.3 – 0.2), but significantly different
at 10 – 60 min UVA (p= 0.001 – 0.01); and between EC at 0 min to BrNMP, not significantly different at 0
min UVA or 60 min D, but significantly different at 10 – 60 min UVA (p= 0.04 – 0.001), or 30 min D (p=
0.01).
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Figure 3.8.17. Effects of Visible Light Activated VLP7000, Br200 and BrNMP Titania
(2mg) with PDDA/PSS Sub-coating on E. coli B for 0-60 Minutes
Percent survival of E. coli B (EC) CFU/mL with and without VLP 7000, Br200, and BrNMP Titania on P
Sub-Coating exposed to a cool white 8 Watt bulb for either 0, 10, 20, 30, 40, 50, or 60 minutes or the dark
for 0, 30, or 60 minutes. (Error bars may be too small to see.) Student T-Test indicated significant
difference at an alpha of 0.05 between EC at 0 min to P25, not significantly different at 0 min VL or 30 –
60 min D; significantly different at 10 – 60 min VL (p= 0.01 – 0.003); between EC at 0 min to Br200, not
significantly different at 0, 2, 4, or 6 min VL or 30 – 60 min D (p= 0.3 – 0.2), but significantly different at 8
– 60 min VL (p= 0.002 – 4 x 0-11); and between EC at 0 min to BrNMP, not significantly different at 0 min
VL or 30 – 60 min D, but significantly different at 10 – 60 min VL (p= 0.02 – 0.002).
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Figure 3.8.18. Effects of Visible Light Activated VLP7000, Br200 and BrNMP Titania
(2mg) with Binder Sub-coating on E. coli B for 0-60 Minutes
Percent survival of E. coli B (EC) CFU/mL with and without VLP 7000, Br200, and BrNMP Titania on B
Sub-Coating exposed to a cool white 8 Watt bulb for either 0, 1, 2, 4, 6, 8, 10, 20, 30, 40, 50, or 60 minutes
or the dark for 0, 30, or 60 minutes. (Error bars may be too small to see.)
Student T-Test indicated significant difference at an alpha of 0.05 between EC at 0 min to vlp7000, not
significantly different at 0 or 10 min VL or 30 – 60 min D; significantly different at 20 – 60 min VL (p=
0.005 – 0.001); between EC at 0 min to Br200, not significantly different at 0, 2, 4, or 6, min VL or 30 –
60 min D (p= 0.3 – 0.2), but significantly different at 8 – 60 min VL (p= 0.01 – 0.0002); and between EC at
0 min to BrNMP, not significantly different at 0 min VL or 30 – 60 min D, but significantly different at 10
– 60 min VL (p= 0.04 – 0.0002).

103

3.9 Tables
Table 3.9.1. Surface chemical analysis P25 or Br200 Titania in powder form

X-ray Photoelectron Spectroscopy of Titania in Powder Form

P25

Brookite-200

Peak

[Mass] %

Peak

[Mass] %

O 1s

39.73

O 1s

38.97

Ti 2p

48.22

Ti 2p

50.39

C 1s

12.06

C 1s

8.33

----

----

Cl 2p

2.31
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Table 3.9.2. Surface chemical [Mass] % analysis of P or B Sub-coatings with or without
Titania

X-ray Photoelectron Spectroscopy of Titania Coatings
PSS

PSS+Br200

PSS+P-25

Na 1s

7.94

8.68

12.93

6.56

5.88

5.88

O 1s

24.63

32.79

28.96

21.87

32.3

34.68

Ti 2p

0

6.81

10.5

0

5.2

9.77

N 1s

3.32

3.73

2.46

5.58

3.68

2.26

C 1s

57.24

32.12

33.01

61.6

34.21

26.67

S 2p

6.88

4.3

5.12

4.39

5.61

3.92

Si 2p

0

11.57

8.02

0

13.09

16.81
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PSS+ BrNMP PSS+vlp7000

PSS+
Anatase

PEAK

Table 3.9.3. Hydrophilicity measured by contact angle on P or B Sub-coatings with or
without Titania

Contact Angle

P Sub-Coating

B Sub-Coating

Alone

< 1o

Alone

62.5o

P25

< 1o

P25

51.5o

Br200

< 1o

Br200

52.5o

vlp7000

< 1o

vlp7000

105.0o

BrNMP

< 1o

BrNMP

67.5o

P Sub-Coating with or without all types of Titania are significantly different at an alpha of 0.05 from all B
Sub-Coatings with or without all types of Titania with a range of p values from 2.36 x 10-5 to 6.93 x 10-6.
All B Sub-Coatings with or without all Types of Titania compared to all B Sub-coatings with or without all
Types of Titania at an alpha of 0.05 were all significantly different from each other (p=0.016 to 3.15 x 106
).
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CHAPTER FOUR
EFFECTS OF PHOTOCATALYTICALLY ACTIVATED POLYMORPHIC
BROOKITE TITANIA NANOPARTICLE WITH ENHANCED VIA NOVEL
SUB-COATTINGS ON CANCER CELL VIABILITY in vitro

(As a manuscript formatted for submission to the Journal of Nanobiotechnology)

4.1 Abstract
The most common form of cancer in the U.S. is skin cancer. The most dangerous
type of skin cancer is melanoma. Exposure to sunlight or ultraviolet (UV) light causes
about 65%-90% of melanoma incidence in the states. Current skin cancer treatments may
involve surgery, radiation therapy, photodynamic therapy, hyperthermia therapy, and
topical or systemic chemotherapy. For minimal skin cancers, a patient friendly product is
needed. Titanium dioxide, a versatile non-selective compound with photocatalytic
properties, degrades compounds through photo-oxidation and exists in three lattice
phases, Anatase, Brookite, and Rutile. This study evaluated liquid band-aid with liquid
phase deposition of polymorphic Brookite phase Titania. Br200 a Water-based Ambient
Condition Sol (WACS) was coated onto liquid band-aid and assessed for cytotoxicity on
cancer cells in vitro.
Long range ultraviolet light (UVA) photocatalytically activated P25 or Br200
Titania with or without liquid band-aid was evaluated for cytotoxicity on HT-29 Human
Colon Cancer Cells or HTB-67 Human Malignant Melanoma Cells in vitro. Both cell
types resulted in a similar trend. Br200 under UVA without liquid band-aid eliminated
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both cell types within 30 minutes. Br200 under UVA with liquid band-aid or P25 under
UVA with and without liquid band-aid eliminated all cells within 60 minutes. P25 in the
dark with and without liquid band-aid killed approximately 0.5 log of cells. Cells under
UVA alone or with liquid band-aid remained at the initial concentration. Except for
variables containing P25, all dark exposed cells remained viable at the initial
concentration.
Light intensity, wavelength, surface material characteristics, pH, types of ionic
molecules in surrounding areas, and target load affect efficiency of photo-oxidation. The
Br200 5-8nm diameter crystallite size range provides a greater surface area, significantly
increasing target contact probability. Br200 Titania indicated superior photo-oxidative
activity when exposed to UVA than the commercial P25 on both HT-29 and HTB-67
cells. This novel format of using FDA approved liquid band-aid coated on one side with
Br200 non-selective Titania coating may provide lower pain and scarring for removal of
cancer cells.

4.2 Introduction
In the U.S., skin cancer is most prevalent with melanoma the most dangerous type
and the third most common. Exposure to ultraviolet (UV) light or sunlight causes about
65%-90% of the melanomas [47]. In the U.S., 2006, melanomas of the skin were
diagnosed in 53,919 people and 8,441 people died [48]. Current skin cancer treatments
may involve surgery, radiation therapy, external beam radiation, photodynamic therapy,
topical, systemic, or fractionated dose chemotherapy, biotherapy, immunotherapy, and
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local hyperthermia [49]. These treatments can cause devastation systemically throughout
the body along with hair loss and other undesirable effects.
Titania or Titanium dioxide (TiO2), is a versatile non-selective compound with
photocatalytic properties, degrades compounds through photo-oxidation. Titanium
dioxide exists in three different polymorphic lattice phases, Anatase, Brookite, and
Rutile. Rutile phase is the most thermodynamically stable due to its minimal electrostatic
repulsive energy; it is abridged in a linear structure with two of the twelve edges of the
octahedron are shared [8]. Anatase phase shares four edges per octahedron without corner
oxygen sharing. Uniquely, Brookite phase is composed orthorhombically with three
shared edges per octahedron.
Zallen and Moret measured the optical absorption edge of Brookite Titania [9].
Extending throughout the visible light range, Brookite was observed to have a broad
absorption edge in contrast to the steep absorption edges of Anatase and Rutile. In the
evaluated spectral range, no evidence of a direct gap was observed. They suggest that
Brookite phase Titania may function as an indirect-gap semiconductor with an
approximate bandgap of 1.9 eV [9]. In contrast, calculations using the self-consistent
orthogonalized linear-combination-of-atomic-orbitals method, Mo and Ching, 1995
approximated a direct bandgap for Brookite [10]. Other researchers have determined that
all three phases of Titania have similar direct bandgap energies (~3.1 + 0.1 eV) [11].
Banerjee and colleagues report the bandgap values for each phase is Anatase (3.2 eV),
Rutile (3.02 eV), and Brookite (2.96 eV) [12]. Whether direct or indirect, polymorphic
Brookite phase Titania exhibits the lowest bandgap energy.
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Researchers have used Atomic Force Microscope (AFM) to visualize the
antimicrobial photocatalytic activity of photo-activated Titania [12]. This same
phenomenon is expected to work on mammalian cells. The characteristics of a
photocatalyst include its ability to simultaneously adsorb two reactants. Then efficiently
adsorb light (hv > Eg) to reduce and oxidize the adsorbed reactants. The absorbed light
energy must be larger than the bandgap to excite the e- from the valence band to the
conduction band producing an e--h+ pair. In the presence of water and dissolved oxygen
(H2O/O2), the positive holes oxidize water splitting it into .OH and H+. The dissolved
oxygen is reduced by the photo electron of the conduction band, generating superoxide
anions (.O2-). H+ combines with the (.O2-) generating a hydroperoxyl radical, eventually
producing a reactive oxygen species (ROS) H2O2 molecule. The photo induced ROS
hydroxyl radical and hydrogen peroxide cause biocidal catalysis by penetrating cell walls
and cutting DNA strands. The super oxide anion can enter the cell after oxidizing holes
are made. Once inside, hydrogen peroxide and the super oxide anion may become
hydroxyl radical precursors. Once inside the cell wall (Fe2+) may activate hydrogen
peroxide by the Fenton reaction, causing cell death via cell wall destruction and strong
DNA damage.
Phosphate ions from Phosphate Buffered Saline have a very high affinity for the
Titania. Phosphate ions bind to the substrate surface causing the isoelectric point of the
TiO2/aqueous interface to significantly shift downward to pH 2.0 and increasing the
3400cm-1peak intensity measured by vibrational sum-frequency spectroscopy (VSFS).
[62]. The isoelectric point was ~5.5 in the presence of Cl- ions.
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This work investigated one type of polymorphic Brookite phase Titania, Br200,
and the commercial Titania P-25 from Degussa, Germany consisting of Anatase phase
79% to the Rutile phase of 21% on liquid band-aid (LB). The samples will be evaluated
for their photocatalytic ability with exposure to UVA 365 nm on Human Colon Cancer
cells HT-29 and Human Malignant Melanoma Cells HTB-67. The Titania-LB will be
examined via Fourier Transform-Infrared Spectrometry.

4.3 Results
Fourier Transform-Infrared Spectrometry verified that Titanium molecules were
present in the LB coatings (Figure 1). XPS spectral graphs of the LB sub-coating with
and without P25 or Br200 are depicted in Figures 4.8.1 and 4.8.2, respectively.
Long range ultraviolet light (UVA at 365nm) photocatalytically activated P25 or
Br200 Titania with or without liquid band-aid were evaluated for cytotoxicity on HT-29
Human Colon Cancer Cells or HTB-67 Human Malignant Melanoma Cells in vitro.
Figure 4.8.3 depicts representative photos of the cells. Figures 4.8.4 (p = 0.01 to 0.00003)
and 4.8.5 (p = 0.02 to 0.00003) depict the quantitative graphs of Viable Cells at different
time points of treatments. Both cell types resulted in a similar trend. Br200 under UVA
without LB eliminated both cell types within 30 minutes. Br200 under UVA with liquid
band-aid or P25 under UVA with and without LB eliminated all cells within 60 minutes.
P25 in the dark with and without LB killed approximately 0.5 log of cells. Cells under
UVA alone or with LB remained at the initial concentration. Except for variables
containing P25, all dark exposed cells remained viable at the initial concentration.
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4.4 Discussion
Fourier Transform-Infrared Spectrometry verified that Titanium molecules were
present in the LB coatings, allowing the Titania to have direct contact with the organic
substance to be degraded. Low temperature calcination of 200oC for 2 h on both Br200
Titania produced crystallite sizes ranging from 5-8 nm, therefore, providing a very high
surface area ranging from (BET) 138 - 157 m2 /g [65]. This provides a significantly
greater surface area per particle than the Degussa commercial P25 reference standard at
(BET) 56 m2/g with 79% Anatase and 21% Rutile phase TiO2. FT-IR Spectral graphs are
shown in Figure 4.8.1 comparing P25 to Figure 4.8.2 Br200 Titania with and without LB.

4.5 Conclusions
According to the results obtained in this study, Br200 Titania with and without
LB provided superior oxidative activity on both HT-29 and HTB-67 cancer cell
decomposition compared to the commercial P25 TiO2 from Degussa, (Evonik Industries
AG, Germany). One explanation is reported by Zallen and Moret, 2006. At ambient
temperature, natural Brookite TiO2 crystals were examined via optical-absorption ranging
from 2.1 to 3.54 eV. The Brookite TiO2 absorption edge is broad, continuing throughout
the visible range with no direct gap [9]. In contrast to tetragonal forms, the orthorhombic
structure encompasses a larger range of bond lengths from the six unique nearestneighbor Ti-O bond lengths. They suggest that Brookite TiO2 has indirect-band-gap
semiconductor properties with a bandgap approximating 1.9 eV. The narrowing off the
band gap will shift the absorption edge into the visible range.
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Due to the low temperature method in which the Br200 was formed and calcined,
provided small crystallite sizes ranging from 5 – 8 nm in diameter, producing a large
surface area, approximately (BET) 157 m2/g [66]. This large surface area would provide
more opportunities for contact with molecules or cells. The smaller crystallite size allows
for more particles to make up a specific mass, hence providing extremely large surface
area for photocatalytic activity.
Therefore, LB coatings with Br200 Titania may provide a non-selective method
of killing cancer cells that causes less pain and less scarring, and deliver a patient friendly
and effective cancer treatment.

4.6 Experimental
Titanium dioxide Br200 nanoparticles samples were graciously given to our lab
by Dr. B. I. Lee and Dr. S. Kaewgun at Clemson University. The donated Br200
nanoparticles were made by the WACS process as described in [66]. This sample was
calcined at 200oCelsius for 2 hours (h) in air. The commercial TiO2, P25 from Degussa,
(Evonik Industries AG, Germany) was used for long wave ultraviolet light (UVA)
(365nm) comparisons of activity to Br200.
FTIR analysis was performed using a Thermo-Nicolet Magna 550 FTIR
spectrometer equipped with a Thermo-Nicolet Nic-Plan FTIR Microscope. Thin films of
the gels (New Skin Liquid Band-Aid; Prestige Brands, Inc., USA) with and without
Br200 or P25 were cast onto IRTran Plates and dried under an IR heat lamp. Scans (64)
at a resolution of 4cm-1 were collected for the sample and also for the background (clean
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IRTran Plate) in transmission mode on the microscope. Samples were analyzed over the
range of 4000cm-1 to 700cm-1. Data was analyzed using Omnic Data Analysis software
and absorbance peaks labeled with wavelength (cm-1).
Each Titania, Br200 or P25, or was mixed into sterile Hanks Balance Salt
Solution (HBSS) sonicated for 1 h and vortexed for 1 minute. A thin coat of LB was
painted onto wax paper matching the size of the well bottom of the 24-well plate. After
drying, 150 µL of the appropriate Titania-HBSS was deposited and air dried for use.
The cell culture assays were conducted using HTB-67 Human Malignant
Melanoma Cells and HT-29 Human Colon Cancer Cells (HTB-38; ATCC, Manassas,
VA). The cells were shipped cryopreserved at the end of their tertiary culture in the
appropriate culture medium and 5% dimethylsulfoxide (DMSO) (Sigma, St. Louis, MO).
Based on ATCC's product information sheet, HTB-67 cells were spherical and grew in
suspension using 15 mL of medium Eagle’s Minimum Essential Medium (EMEM) and
10% Fetal Bovine Serum (FBS). HT-29 cells are epithelial and adherent growing in
ATCC-formulated McCoy's 5a Medium Modified, Catalogue No. 30-2007, plus 1%
antibiotic solution with FBS to a final concentration of 10%. They were subcultivated in
T-75 culture flasks (Corning canted neck flasks with vented caps, (VWR, Atlanta, GA) in
a 37°C, 5% CO2, 95% air, humidified culture incubator with Work was carried out in a
class 2 A/B3 biological safety cabinet. Hanks' Balanced Salt Solution (HBSS) plus 1%
antibiotic solution, modified without calcium chloride, magnesium chloride, or phenol
red (ATCC 30-2213) was used for washing cells and the test experiments. For tests, 1 X
105 cells/38cm2 were inoculated and grown to 90% confluency in 24-well tissue culture
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treated plates (VWR, Atlanta, GA). Cells were rinsed in HBSS twice prior to testing and
HBSS was the testing diluent. HBSS had the least affect on the Titania.
LIVE/DEAD® Viability/Cytotoxicity Kit— (Molecular Probes; Eugene, OR)
Calcein AM EX/EM 494/517 is membrane-permeant, cleaved by esterases in live cells
resulting in cytoplasmic green fluorescence. Ethidium homodimer-1 EX/EM 517/617 is
membrane-impermeant and labels nucleic acids of membrane-compromised cells with
red fluorescence. The cells were exposed to either UVA 365nm at 363-364 µW/cm2 or
dark for different time periods with and without Br200 or P25 Titania, using 1mg/mL
free suspension or 2mg/38mm2 coatings. Following the Live/Dead product sheet, the
cells were incubated for 1 h then observed and photographed under a fluorescent
microscope. There were 4 wells per variable with 4 random pictures taken per well.
Cells were observed for morphology and life.
The Titania were weighed and mixed into HBSS at either 1mg/ml in free
suspension or 14mg Titania/mL HBSS for the coatings. The liquid Titania suspensions
were sonicated (Sonicator FS30H; Fisher Scientific) for 1 h and vortexed. Each well
received 1mg/mL of either Br200 or P25 Titania. Each treated liquid Band-aid (LB) slip
received one aliquot of 150 µL of Br200 or P25 suspension, (2mg/38mm2) and was air
dried at ambient temperature between aliquots, then stored aseptically at room
temperature for further use.
Phosphate Buffered Saline (PBS) was not used as the diluent because Phosphate
ions from Phosphate Buffered Saline have a very high affinity for the Titania. Phosphate
ions bind to the substrate surface causing the isoelectric point of the TiO2/aqueous
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interface to significantly shift downward to pH 2.0 and increasing the 3400cm-1peak
intensity measured by vibrational sum-frequency spectroscopy (VSFS) [62].
The LB coating with or without Br200 or P25 Titania was evaluated for
photocatalytic activity. Cells alone without treatment were the negative control and cells
with free suspension Titania were used for the positive controls. A multiple ray lamp
(MRL, Model 58; Fisher Scientific) with different 8 Watt tubes UVA (365nm) at 363-364
µW/cm2) and visible light (Cool White) at 100 µW/cm2) was utilized as the source for
photoactivation. The intensity of light was verified with a UVX Digital Radiometer,
(Model-UVX, UVP, Inc., Upland, CA) for UVA light. Polystyrene plates (24-well)
containing the cells were secured onto a microplate orbital mixer (Microplate Genie,
Model SI-0400, VWR). One milliliter of 1mg/mL Br200 or P25 HBSS solution was
added to each well in free suspension. Each coating was placed into well containing
1X105 cells in HBSS. A non-fluorescing optically clear film (TemPlate® RT Optical
Film, 2978-2700, USA Scientific, Inc.) was adhered to the polystyrene plate to prevent
evaporation of the MO. The lamp intensity was adjusted to accommodate the film and the
liquid band-aid.
Plates were at 0, 5, 10, 15, 30, and 60 minutes, the experiment was run backward
so the times would come due at the same time for each plate. The cells were washed
twice in HBSS to remove the free Titania. The wells containing had the coatings removed
and cells rinsed twice. The Live/Dead Assay was applied and read after 1 h incubation
using a fluorescent microscope. Four random images were taken of each sample and the
cells were counted. Calculations were based on the change in viable cells counts at
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various time points as percentages described in Equation 1.

All experiments were

replicated for reproducibility.
_Change in Number of Viable Cells_

X 100%

(1)

Original Cell Concentration
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4.8 Figures

Figure 4.8.1. FT-IF Spectral Graphs of P25 with and without Liquid Band-Aid
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Figure 4.8.2. FT-IF Spectral Graphs of Br200 with and without Liquid Band-Aid
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Figure 4.8.3. Representative Photos of Live/Dead Cytocompatibility HTB-67 Human Malignant
Melanoma Cells exposed to Dark in vitro
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Figure 4.8.4. Representative Photos of Live/Dead Cytocompatibility HTB-67 Human Malignant
Melanoma Cells with and without Titania exposed to UVA in vitro
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Figure 4.8.5. Effects of UVA photoactivation on HTB-67 Melanoma cells by Br200 or
P25 with or without Liquid Band-Aid with p values ranging from 0.01 to 0.00003
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Figure 4.8.6. Effects of UVA photoactivation on HT-29 Colon Cancer cells by Br200 or
P25 with or without Liquid Band-Aid with p values ranging from 0.02 to 0.00003
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CHAPTER FIVE
CONCLUSIONS

As MDR bacteria and biofilms become more prevalent and resistant in both the
nosocomial and community settings, non-selective surface coatings that eradicate these
super bugs are truly needed. In our first study, we created a super-hydrophilicpolyelectrolyte-Brookite phase Titania coating. We obtained positive results in
characterizing the coatings through surface chemical analysis and XRD. We verified that
the polyelectrolyte super-hydrophilic-Brookite phase Titania coating contained the
Titania particles on the surface and that the spectra peaks corresponded to the lattice
structure in the original Brookite phase nanoparticle powered Titania provided to our lab
by Dr. Lee. The polyelectrolyte coatings containing Br200 Titania were superior to
BrNMP, the commercial P25 from Degussa, and the commercial Kronos VLP7000 in
every evaluation in both UVA and VL light against different loads of bacteria. To our
knowledge, this is the first super-hydrophilic-polyelectrolyte-Brookite phase Br200
Titania coating. This novel polyelectrolyte-Br200 non-selective Titania coating can
provide a low cost, effective non-selective method of preventing transmission of bacterial
infections, or prevention of biofilm formation in the nosocomial and community settings.
The Brookite phase Titania was also evaluated on cancer cells, HT-29 human
colon cancer cells and HTB-67 human malignant melanoma cells in vitro. Again, the
Br200 Titania whether in free suspension or used as a coating with liquid band-aid, it
proved significantly superior to the commercial Anatase phase, P25 from Degussa. To
our knowledge, this is the first study to evaluate this novel format of using FDA approved
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liquid band-aid coated on one side with Br200 non-selective Titania coating and can
provide lower pain and scarring for removal of skin cancers in a patient friendly format.
The objectives of this research were obtained. First the free suspension assay was
modified and miniaturized with three different methods. For high bacterial loads, the
BacLight Live Dead Assay and the BacTiterGlo Assay provide a fast and multiple
variable 96-well format for quantitative measurements using fluorescence or
luminescence plate reader and qualitatively using fluorescence microscopy. With a lower
bacterial load, spread plating from a 24-well plate format provides superior low number
counts. The modified and miniaturized assay was adapted for use with coatings. Twentytwo millimeter glass cover slips were used as the coating base and fit in the 22.2 mm
diameter wells of the 24-well plates. Twenty-four samples could be evaluated at one time
with spread plating techniques for quantification.
The novel P sub-coating was developed and characterized via XRD to confirm a
match with the original properties of the loose nanoparticles. XPS further characterized
the molecules present on the surface of the coatings, indicating that Ti, O, N, and S were
on the surfaces. Complete death curves were quantified for each type of Titania, P25,
Br200, BrNMP, and vlp7000 both in free suspension and comparing the new P subcoating with and without Titania to the B sub-coating with and without Titania. The death
curves were performed under UVA or VIS light for the appropriate types of Titania.
Br200 remained superior to all other types of Titania evaluated in the coatings under both
UVA and VIS light. In fact, Br200 with the P sub-coating killed all bacteria within 8
minutes under VIS light. In previous work by our lab’s researchers their coating with
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Br200 required over 8 hours of exposure to kill 3 logs of cells difference from the Br200
cells in the dark.
Methyl Orange oxidative-degradation using the P sub-coating with Br200,
BrNMP and UVA (P25) or VIS light (vlp7000) with an 8 Watt lamp yielded total
degradation. Total degradation occurred under UVA and P sub-coatings with Br200 and
BrNMP in 10-12 hours and under VIS light and P sub-coatings with Br200 and BrNMP
in 14 hours. These results indicate the uniqueness of the P sub-coating bound with the
Br200 and BrNMP Titania.
Because of these results of the P sub-coating with the polymorphic Brookite
Br200 and BrNMP, low temperature surface interactions between the P sub-coating N
and/ or S molecules and the Titania may occur. These molecules are enhancing the
photocatalytic activity of the polymorphic Brookite Br200 and BrNMP by increasing the
absorption edge and narrowing the ban-gap. To our knowledge, this is the first time that
low temperature interactions via the P sub-coating, positively affecting Titania
photocatalytic properties in this manner has been described. Therefore, this work
contributes to the scientific body of knowledge. The P sub-coating is novel and has
enhancing abilities to increase the photocatalytic activity of polymorphic Brookite,
Br200, and BrNMP.
Due to the superior results of Br200, it was chosen for the in vitro cancer work as
a feasibility proof of concept model. Br200 and P25 were examined with the LB subcoating to kill cancer cells under UVA irradiation. Again, Br200 with the FDA approved
LB sub-coating was found superior. This work may contribute to the enrichment of
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cancer patients’ lives, by receiving treatment that is less deleterious throughout the body,
causes less scarring and pain. Finding a new treatment for cancer also contributes to the
scientific body of knowledge.
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RECOMMENDATIONS

The super-hydrophilic-Brookite phase Br200 Titania coating should be
characterized further by evaluating to verify the coated Titania retains the same
characteristics as the original nanoparticle powder. Characterize and verify in detail how
the P sub-coating containing the N and S molecules enhance the polymorphic Brookite
Br200 and BrNMP Titania.
1. Solid state 1H MAS NMR measurements, used to distinguish and analyze the
amount of surface hydroxyls and lattice hydroxyls as minimization increases
photocatalytic activity
2. N2 physisorption to verify BET surface area, pore volume, average pore diameter,
and pore size distribution of TiO2 on coatings
3. Fourier-Transform Infrared Spectroscopy (FT-IR) to verify vibrational bands for
total water and -OH groups on coatings
4. ATR for the semiquatitative analysis of hydroxyls on coatings
5. Diffuse Reflectance Infrared Fourier Transform (DRIFT) spectroscopy to confirm
that the ATR is valid for the semiquatitative analysis of hydroxyls
Because, light intensity, wavelength, surface material characteristics, and bacterial
load affect efficiency of photo-oxidation, further evaluation of the novel P sub-coating is
warranted.
6. Different loads of and species of bacteria should be evaluated under both UVA
and VL light on the novel sub-coatings with Titania
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7. Test comparing VL light on the novel sub-coatings with Titania
8. Different strains of human melanomas on the LB novel sub-coatings with Titania
9. Observe the effects in an in vivo murine model. The immunohistochemistry
marker HMB-45 will stain malignant melanoma.
10. Test more variables and reproducibility in the in vivo work for statically
significant results
11. Further characterization of the liquid band-aid-Br200 coating to verify the Br200
Titania as listed above with the first coating.
12. File for IP
13. Look into Clinical Trials
14. Work on product development
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APPENDIX A
LAMP WAVELENGTH SPECTRA
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A.1. Visible Wavelength Spectra: Emission range of Cool White 8 Watt Lamp for VL
work, UVP, Inc., Upland, CA
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Relative Power

Wavelength (nm)
Figure A.2. Spectra emission wavelength range of 365nm with filter 8 Watt Lamp for
UVA work, UVP, Inc., Upland, CA
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APPENDIX B
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B. XPS Spectral Graphs
XPS data table of PSS/PDDA (P) Sub-Coating
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XPS spectral graph of PSS/PDDA Sub-Coating
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XPS high resolution data table of PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Sodium 1s in PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Oxygen 1s in PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Nitrogen 1s in PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Carbon1s in PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Sulfur 2p in PSS/ PDDA Sub-Coating
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XPS data table of P25 TiO2 with PSS/PDDA Sub-Coating
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XPS spectral graph of P25 TiO2 with PSS/PDDA Sub-Coating
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XPS high resolution data table of P25 TiO2 with PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Sodium 1s in P25 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Titanium 2p in P25 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Carbon 1s in P25 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Sulfur 2p in P25 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Silicon 2p in P25 TiO2 with PSS/PDDA SubCoating
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XPS data table of Br200 TiO2 with PSS/PDDA Sub-Coating
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XPS spectral graph of Br200 TiO2 with PSS/PDDA Sub-Coating
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XPS high resolution data table of Br200 TiO2 with PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Sodium 1s in Br200 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Oxygen 1s in Br200 TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Nitrogen 1s in Br200 TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Carbon 1s in Br200 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Sulfur 2pin Br200 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Silicon 2p in Br200 TiO2 with PSS/PDDA SubCoating
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XPS data table of BrNMP TiO2 with PSS/PDDA Sub-Coating
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XPS spectral graph of BrNMP TiO2 with PSS/PDDA Sub-Coating
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XPS high resolution data table of BrNMP TiO2 with PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Sodium 1s in BrNMP TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Oxygen 1s in BrNMP TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Titanium 2p in BrNMP TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Nitrogen 1s in BrNMP TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Carbon 1s in BrNMP TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Sulfur 2p in BrNMP TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Silicon 2p in BrNMP TiO2 with PSS/PDDA
Sub-Coating
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XPS data table of vlp7000 TiO2 with PSS/PDDA Sub-Coating
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XPS spectral graph of vlp7000 TiO2 with PSS/PDDA Sub-Coating
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XPS data table of vlp7000 TiO2 with PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Sodium 1s vlp7000 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Oxygen1s vlp7000 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Titanium 2p vlp7000 TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Nitrogen 1s vlp7000 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Carbon 1s vlp7000 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Sulfur 2p vlp7000 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Silicon 2p vlp7000 TiO2 with PSS/PDDA SubCoating

189

XPS data table of vlp7001 TiO2 with PSS/PDDA Sub-Coating
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XPS spectral graph of vlp70001 TiO2 with PSS/PDDA Sub-Coating
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XPS data table of vlp7001 TiO2 with PSS/PDDA Sub-Coating
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XPS high resolution spectral graph of Oxygen 1s vlp7001 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Titanium 2p vlp7001 TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Nitrogen 1s vlp7001 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Carbon 1s vlp7001 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Chlorine 2p vlp7001 TiO2 with PSS/PDDA
Sub-Coating
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XPS high resolution spectral graph of Sulfur 2p vlp7001 TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Silicon 2p vlp7001 TiO2 with PSS/PDDA SubCoating
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XPS data table of Anatase TiO2 with PSS/PDDA Sub-Coating
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XPS spectral graph of Anatase TiO2 with PSS/PDDA Sub-Coating

201

XPS high resolution data table of Anatase TiO2 with PSS/PDDA Sub-Coating

202

XPS high resolution data table of Anatase TiO2 with PSS/PDDA Sub-Coating
(Continued)
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XPS high resolution spectral graph of Sodium 1s in Anatase TiO2 with PSS/PDDA SubCoating

204

XPS high resolution spectral graph of Oxygen 1s in Anatase TiO2 with PSS/PDDA
Sub-Coating

205

XPS high resolution spectral graph of Titanium 2p in Anatase TiO2 with PSS/PDDA
Sub-Coating

206

XPS high resolution spectral graph of Nitrogen 1s in Anatase TiO2 with PSS/PDDA
Sub-Coating

207

XPS high resolution spectral graph of Carbon 1s in Anatase TiO2 with PSS/PDDA SubCoating

208

XPS high resolution spectral graph of Chlorine 2p in Anatase TiO2 with PSS/PDDA
Sub-Coating

209

XPS high resolution spectral graph of Sulfur 2p in Anatase TiO2 with PSS/PDDA SubCoating
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XPS high resolution spectral graph of Silicon 2p in Anatase TiO2 with PSS/PDDA
Sub-Coating
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APPENDIX C
XRD SPECTRA GRAPHS OF TITANIA WITH P OR B SUB-COATINGS
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XRD spectral graph of PSS/PDDA alone on glass cover slip
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Meas. data:P25/Data 1
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XRD spectral graph of PSS/PDDA with P25 TiO2 on glass cover slip

214

35

Meas. data:Br200/Data 1
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XRD spectral graph of PSS/PDDA with Br200 TiO2 on glass cover slip
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Meas. data:BrNMP/Data 1
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XRD spectral graph of PSS/PDDA with BrNMP TiO2 on glass cover slip
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Meas. data:VLP7000/Data 1
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XRD spectral graph of PSS/PDDA with BrNMP TiO2 on glass cover slip
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Meas. data:binder/Data 1

Intensity (cps)

80

60

40

20

0
20

25

30

2-theta(deg)

XRD spectral graph of Binder alone on glass cover slip
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Meas. data:BindP25/Data 1
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XRD spectral graph of Binder with P25 TiO2 on glass cover slip
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Meas. data:subBr200/Data 1
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XRD spectral graph of Binder with Br200 TiO2 on glass cover slip
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Meas. data:coatBrNMP/Data 1
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XRD spectral graph of Binder with BrNMP TiO2 on glass cover slip
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Meas. data:bindVLP7000/Data 1
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XRD spectral graph of Binder with vlp7000 TiO2 on glass cover slip
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APPENDIX D
P SUB-COATING STRUCTURES AND COMPONENTS

223

Poly(diallyldimethylammonium chloride) solution (PDDA)
Line formula: (C8H16ClN)n

Poly(4-styrenesulfonic acid) solution (PSS)
Line formula: (C8H8O3S)n
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